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A COMPREHENSIVE REVIEW OF THE  
AMNIOTIC MEMBRANE AND AMNIOTIC FLUID 
JOSEPH ANTHONY BRAZZO III 
 
ABSTRACT 
 The amniotic membrane and the amniotic fluid are one of life’s most 
complex and delicate tissues and fluids, respectively.  What was known about 
this tissue and fluid prior to the 20th century was extremely limited scientifically, 
but was significantly defined by beliefs entrenched in mysticism, folklore, and 
superstitions. A comprehensive literature review of the amniotic membrane tissue 
and amniotic fluid reveals the many unique and complex characteristics and 
biological properties that been heavily investigated since the turn of the 20th 
century and continues to surge into the 21st century. The historical perspectives, 
evolution, derivation, histology, structure, and composition of the amniotic 
membrane; and historical perspectives, volume and regulation, and cellular and 
non-cellular composition of the amniotic fluid are discussed here and are 
coalesced for an easy and comprehensible resource. Lastly, future perspectives 
regarding research and application of the amniotic membrane and amniotic fluid, 
including stem cells are discussed.  
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CHAPTER 1 
INTRODUCTION 
The amniotic sac is composed of the amniotic membrane (AM) and 
amniotic fluid (AF) (Larsen, 1997). It contains life’s most delicate and sensitive 
creation, the developing embryo and fetus (Larsen, 1997). Together the AM and 
AF must maintain an internal environment capable of sustaining life in the 
presence of a fluctuating, dynamic external environment (Underwood, Gilbert, & 
Sherman, Amniotic fluid: not just fetal urine anymore., 2005). It is with no surprise 
that the AM and AF are of the most complex tissues and fluids in the human 
body, respectively (Larsen, 1997). It is only recently within the past century have 
the many characteristics and biological properties of the AM and AF been 
discovered (Trelford & Trelford-Sauder, 1979).  
Scientific investigation of the AM and AF was sparse before the 20th 
century (Trelford & Trelford-Sauder, 1979). Reference of the AM and AF date 
back to Ancient Egypt; and for centuries following, mystery, superstition and 
folklore defined the state of knowledge of the AM and AF (Longo & Reynolds, 
2010; Crawford-Mowday, 2009; The Learning Company, 1997). The turn of the 
20th century marks a major transition of the state of knowledge of the AM and AF 
from mystery to significant scientific inquiry (Trelford & Trelford-Sauder, 1979). A 
compendium of historical perspectives is pertinent to grasp the current state of 
knowledge and research of this tissue and fluid (Longo & Reynolds, 2010). 
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However, the many beliefs of the AM and AF of various cultures are both 
intriguing and educational (Longo & Reynolds, 2010). Historical perspectives 
before the 20th century and after the 20th century on the AM and AF are 
discussed in the beginning of their associated chapters. 
A detailed review of the historical perspectives, evolution, embryology, 
histological structure and immunohistochemistry, and biological properties of the 
AM are discussed in Chapter 2. Chapter 3 includes a detailed review of the 
historical perspectives, volume and regulation, non-cellular composition, and 
non-stem cell and stem cell composition of the AF. Most importantly, in chapter 4 
the future direction of research regarding this tissue and fluid are discussed. 
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CHAPTER 2 
THE AMNIOTIC MEMBRANE 
2.1 Historical Perspectives 
2.1.1 Pre-20th Century 
Scientifically, little was known about the AM prior to the 20th century 
(Trelford & Trelford-Sauder, 1979). Knowledge on the AM during this period was 
the product of heavy interests in and fascination for embryology, specifically the 
development and creation of life (Longo & Reynolds, 2010; Trelford & Trelford-
Sauder, 1979). A search on pre-20th century literature on the AM reveals an 
acquisition of scientific knowledge non-specific for the membrane itself. More 
specifically, scientific knowledge on the AM was often the result of the 
investigation on the placenta including the chorionic membrane (CM) without 
specification (Longo & Reynolds, 2010; Trelford & Trelford-Sauder, 1979). For 
this reason historical perspectives on embryological tissues as they pertain to the 
AM are included in this section.   
Although scientific knowledge on the AM prior to the 20th century was 
limited, the state of knowledge on the AM wholly was entrenched in mysticism, 
folklore, as was most of medicine (Longo & Reynolds, 2010; Trelford & Trelford-
Sauder, 1979). This mysticism and folklore brought about superstitions and 
beliefs of the AM ranging from immortality to black magic (Longo & Reynolds, 
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2010). Also, many religious texts throughout history make reference to the AM 
(Longo & Reynolds, 2010; Carr, 2004; Elsaie, 2004; Olivelle, 1998; Shakya, 
1998). The mutuality of scientific knowledge, mysticism and folklore, and 
religious reference of the AM pre-20th century should not be overlooked (Longo & 
Reynolds, 2010; Trelford & Trelford-Sauder, 1979). Such mutuality provides 
insight into the acquisition of knowledge of the AM throughout history, and 
heavily emphasizes the importance and delicacy of this tissue (Longo & 
Reynolds, 2010; Trelford & Trelford-Sauder, 1979). Historical perspectives on the 
AM pre 20th century are explored chronologically.  
2.1.1.1 Ancient Egypt (3100BCE–300BCE)  
In Ancient Egypt the Goddess of fertility and motherhood was Isis (The 
Learning Company, 1997). Isis was described to possess great magical powers, 
including the powerful ability to create and destroy life (The Learning Company, 
1997). Ancient Egyptians that placed Isis and her husband, Osiris, at the center 
of Egyptian deities were deemed the “cult of Isis” (The Learning Company, 1997). 
In early Ancient Egypt there was only a small fraction of those following the cult 
of Isis (The Learning Company, 1997). Popular belief among Ancient Egyptian 
civilization was that a baby born with the “caul” was destined for the cult of Isis 
(The Learning Company, 1997). Discussed below in more detail, a “caul” is the 
AM covering of a fetus during birth (Trelford & Trelford-Sauder, 1979).  
2.1.1.2 Vedic Period (1700BCE–500BCE) 
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 The Upanishads are the core philosophical texts of the Hindu religion 
(Olivelle, 1998). They are a collection of scriptures believed to teach the 
fundamental principles of the universe and mankind through reader introspection, 
inner spirituality, and philosophy (Olivelle, 1998). Writing of the Upanishads 
scriptures is believed to have spanned several hundred years from 800 BCE to 
400 BCE (Olivelle, 1998). With over 200 Upanishads, there are, however, 
thirteen principle Upanishads (Olivelle, 1998). One of the thirteen principle 
Upanishads is the Chāndoya Upanishad (Olivelle, 1998). The Chāndoya 
Upanishad, “you are that”, seeks to explain the origin of the universe (Olivelle, 
1998). Interestingly, in the Chāndoya Upanishad we are told that the universe 
developed from an egg that split in two upon hatching (Olivelle, 1998). The first 
half became silver, representing the Earth, and the second half became gold, 
representing the sky (Olivelle, 1998). We are told of the existence of two 
membranes of the egg, which have figurative representation, the outer 
membrane being the mountains, and the inner membrane, the amniotic 
membrane, being the clouds and mist (Olivelle, 1998). This is possible indication 
that the biological membranes, including the AM, were known to exist among 
people of Asian continent; however, we do are not informed to what extent 
(Olivelle, 1998).  
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2.1.1.3 Ancient Greece (1200BCE–300BCE)  
Hippocrates of Cos is considered the father of embryology (Power & 
Schulkin, 2012; Longo & Reynolds, 2010). His study of embryology would 
establish a school of thought that would continue well into the medieval ages 
(Power & Schulkin, 2012; Longo & Reynolds, 2010). Hippocrates’s scientific 
investigation of the embryology was very limited, and often being the product of 
philosophical logic and the study of chick embryos (Power & Schulkin, 2012). 
Hippocrates believed that the growing fetus would nourish itself from the suckling 
of “uterine paps” of the uterine wall (Power & Schulkin, 2012). No mention of the 
AM specifically can be found in Hippocrates’s notes on embryology (Power & 
Schulkin, 2012).  
Many of Aristotle’s discoveries in embryology would challenge 
Hippocrates’s embryology school of thought (Power & Schulkin, 2012; Longo & 
Reynolds, 2010). Aristotle’s study of embryology was heavily based on 
experiments and dissections of various animals’, however, never humans (Power 
& Schulkin, 2012). Many of Aristotle’s conclusions of embryology on studied 
animals have been shown to be largely correct (Longo & Reynolds, 2010). 
Aristotle largely refuted Hippocrates’s “uterine paps” (Power & Schulkin, 2012). 
Using chick embryos, Aristotle showed that a chick fetus was encased in 
membranes and thus suckling could not be possible as claimed by Hippocrates 
(Power & Schulkin, 2012; Longo & Reynolds, 2010). Aristotle believed 
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nourishment of the fetus was through the umbilical cord directly connected to the 
uterus of the mother; however, he incorrectly postulated that meternal and fetal 
blood were one (Power & Schulkin, 2012; Longo & Reynolds, 2010). It can be 
said that Aristotle was the first to scientifically acknowledge fetal membranes 
(Power & Schulkin, 2012). However, differentiation of the AM from the CM and 
placenta by Aristotle is not noted (Power & Schulkin, 2012; Longo & Reynolds, 
2010). 
2.1.1.4 Ancient Rome (500BCE–400AD) 
In Ancient Rome Claudius Galenus (Galen) of Pergamos, a Greek 
physician-scientist made significant contributions to the field of embryology 
(Longo & Reynolds, 2010). Galen was the physician to multiple Roman emperors. 
Not only was Galen a physician, he was also a diligent anatomist (Longo & 
Reynolds, 2010). Galen performed a great amount of dissections on Barbary 
macaques (Power & Schulkin, 2012; Longo & Reynolds, 2010). Galen’s 
conclusions in embryology opposed Hippocrates’s conclusions in embryology, 
and supported Aristotle’s (Power & Schulkin, 2012; Longo & Reynolds, 2010). 
Galen believed that the uterus of the mother would latch on to the CM of the 
developing fetus (Longo & Reynolds, 2010). There are no indications that the CM 
Galen refers to include the AM; however, because of the fineness of the fetal 
membranes the distinction of multiple membranes during this period and before 
was impractical (Longo & Reynolds, 2010; Trelford & Trelford-Sauder, 1979).  
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2.1.1.5 Medieval Period (400AD-1400AD) 
 The prophet Muhammad wrote the religious text of the Islamic faith, the 
Quran, in the early 7th century. In the noble Quran (نآر ق) the word of the Lord, 
Allah, references indirectly the AM by indicating the creation of life developing in 
three veils of darkness within the womb of the mother (Elsaie, 2004). Surah 39, 
Ayah 6 “…He creates you in the wombs of your mothers in stages, one after 
another, in three veils of darkness. Such is Allah, your Lord and Cherisher. To 
Him belongs (all) dominion. There is no God but He: Then how are ye turned 
away (from your true Lord)?” (Elsaie, 2004). Scholars of the Qur’an believe the 
first veil is in reference to the abdominal wall of the mother, the second is the 
uterus, and the third is the fetal membranes, including the placenta and AM 
(Elsaie, 2004). Again, it is uncertain if the fetal membranes indicated in the 
Qur’an are distinguished during the time period in which it what was written. 
What we do know is that Islamic scholars knew the developing fetus was 
encased in a membrane, which included the AM (Elsaie, 2004).  
Derived from the Latin word caput galeatum literally meaning “helmeted 
head”, the “caul” or “born with the caul” describes the covering of the head and 
neck of a newborn with AM (Trelford & Trelford-Sauder, 1979). The occurrence 
of such a birth is exceptionally rare with a frequency of about 1 in 80,000 births 
(Trelford & Trelford-Sauder, 1979). Rarer is the birth of a new born fully encased 
within the amniotic sac (Trelford & Trelford-Sauder, 1979). These births are 
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known as “en-cauls” distinct from the “caul” (Trelford & Trelford-Sauder, 1979). 
Mysticism, superstitions, and folklore surrounding the AM during the medieval 
ages can be significantly attributed to the babies born with the “caul” (Crawford-
Mowday, 2009; Trelford & Trelford-Sauder, 1979). In the late medieval ages it 
was thought that babies born with a caul or “veil” were inherently destined for 
greatness, providing them with good luck and protection from intangible evil 
forces (Crawford-Mowday, 2009). Often, a midwife removed the caul of a 
newborn by pressing a piece of paper onto the caul of the head and neck 
(Crawford-Mowday, 2009; Trelford & Trelford-Sauder, 1979). The removed caul 
attached to the paper was given to the mother of the baby as an heirloom 
(Crawford-Mowday, 2009; Trelford & Trelford-Sauder, 1979). Sailors in the late 
medieval ages and early modern period highly valued cauls (Crawford-Mowday, 
2009). It was believed that a caul provided good luck on sea journeys, and also 
gave the sailor in possession of a caul safety from death of drowning (Crawford-
Mowday, 2009). Considered a sailor’s charm, many sailors paid considerable 
prices to possess one (Crawford-Mowday, 2009). These beliefs would continue 
well into the Early Modern period into the Victorian period, and even into the 
middle 20th century (Crawford-Mowday, 2009).  
In other regions of Europe, particularly Eastern Europe it was believed that 
babies born with a “caul” was evidence that the baby would return from the dead 
(Radford, 2012). This was an indication of the birth of a vampire (Radford, 2012). 
Babies born with a “caul” were immediately killed or grew up and labeled by the 
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public with great suspicion (Radford, 2012). Also, twins born with the caul were 
considered demons (Radford, 2012).  
2.1.1.6 Early Modern Period (1450AD–1750AD) 
Leonardo da Vinci made significant contributions to the field of embryology 
(Gilson, 2013; Longo & Reynolds, 2010). Leonardo da Vinci studied the 
development of organisms in various animal species, particularly the chicken 
embryo (Gilson, 2013). He produced detailed drawings of the developing chicken 
embryos and fetuses (Gilson, 2013). These drawings are still used in embryology 
texts and teachings (Gilson, 2013). Most noted in Leonardo’s detailed drawings 
are the membranes of which the developing fetus is enclosed, including the inner 
AM, CM, allantois, and the umbilical and uterine vasculature (Gilson, 2013). 
These drawings indicate the depth of knowledge and familiarity of the fetus and 
embryological membranes Leonardo had acquired through his own research 
(Gilson, 2013). Nothing specific of the AM is noted in Leonardo’s work (Gilson, 
2013; Longo & Reynolds, 2010). 
 The beliefs and traditions of an agrarian culture situated in the 
mountainous Friuli region of northern Italy held dear the power and superstitions 
of the caul (Ginzburg, 1983). For two centuries beginning in the 16thcentury 
individuals of this region believed the existence of good and evil witches and 
warlocks in perpetual battle (Ginzburg, 1983). The good witches and warlocks 
known as benandanti, “good walkers”, were armed with stalks of fennel, and bad 
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witches and warlocks with sorghum and wooden pallets (Ginzburg, 1983). During 
the night hours these two forces would intensely battle into the twilight of dawn 
for the fertility of the land. If the benandanti won, the harvest would be safe, and 
oppositely, if the evil spirits had won feminine would ensue and also spoil all the 
wine in the local villages (Ginzburg, 1983). It was believed that the souls and 
spirits would exit the human body at night to go forth into battle and returned prior 
to dawn before wakefulness (Ginzburg, 1983). The power harnessed by the 
benandanti was believed to lie in the supernatural abilities of the amnion and 
placenta (Ginzburg, 1983). The spirits and souls of men for which the mother 
preserved the caul or AM was worn about the neck and compelled to go forth into 
battle (Ginzburg, 1983). It was believed that these tissues of the neck 
safeguarded and protected the benandanti from the evil spirits for they did so 
during development of the humanly body before birth (Ginzburg, 1983). 
 The historical perspectives mentioned above do not represent the 
complete picture on all knowledge and beliefs of the amniotic membrane before 
the 20th century. Unfortunately, literature research regarding historical 
perspectives pre-20th century reveals limited and scattered information on the 
subject. These perspectives highlight not only the importance of extra-embryonic 
membranes of the placenta during these times but beliefs and knowledge of such 
tissues were entrenched in mysticism, folklore, and superstitions (Longo & 
Reynolds, 2010). 
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2.1.2 Post-20th Century 
Scientific investigation on the AM became prominent at the beginning of 
the 20th century (Trelford & Trelford-Sauder, 1979). This increase in scientific 
inquiry pushed aside mysticism and folklore that entrenched the state of 
knowledge on the AM prior (Longo & Reynolds, 2010; Trelford & Trelford-Sauder, 
1979). The use of the AM as a skin graft in the 1890s marked the initial scientific 
investigation of the membrane at the turn of the 20th century (Trelford & Trelford-
Sauder, 1979; Davis, 1910). Scientific investigations and acquired knowledge on 
the AM were confined to clinical and therapeutic applications in the first half of 
the 20th century (Trelford & Trelford-Sauder, 1979). EM in the 1940s allowed fine 
structure and cellular investigations of the amniotic membrane, revealing 
membrane morphology, including cellular and non-cellular entities (Trelford & 
Trelford-Sauder, 1979). Discoveries of the membrane’s biological functions and 
translational properties would unfold in the latter half of the 20th century (Dua, 
Gomes, King, & Maharajan, 2004). In the late 20th century, clinical and 
therapeutic applications of the AM would be reinvestigated and optimized, along 
with new applications, since their first use in the early 1900s (Dua, Gomes, King, 
& Maharajan, 2004). Lastly, the discovery of amniotic membrane stem cells in 
the 21st century would bring forth novel clinical therapeutic applications in various 
medical fields (Dobreva, Pereira, Deprest, & Zwijsen, 2010). 
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2.1.2.1 Initial Investigations (1890s-1940s) 
 In 1910 Dr. John Davis of the Johns Hopkins Hospital wrote a 
compendium on the literature and knowledge on skin grafting, including the many 
surgical approaches and various tissues he used (Davis, 1910). Dr. Davis’s 
amniotic membrane skin graft was the first documented clinical application of the 
membrane (Davis, 1910). Although the results of the membrane graft were 
unpromising, Dr. Davis suggested that the amniotic membrane could be of great 
use in skin grafts given advancement in surgical and procurement techniques 
(Davis, 1910). Ultimately, it would mark the transition of scientific investigation of 
the amniotic membrane from vague scientific research of the pre-20th century to 
clinical and therapeutic applications (Davis, 1910).  
In 1913, using new fresh tissue preservation methods implemented by Dr. 
Alexis Carrel, Drs. Stern and Sabella applied AM tissue to both skin burns and 
ulcers (Sabella, 1913; Stern, 1913; Carrel, 1912). Drs. Stern and Sabella 
performed independent studies; however, they often collaborated, sharing data 
and strategies (Sabella, 1913; Stern, 1913). Following, scientific research on the 
amniotic membrane declined and would not regain inquiry for some thirty years 
(Dua, Gomes, King, & Maharajan, 2004; John, 2003). 
The creation of an artificial vagina using AM marked the resurgence of 
scientific inquiry on the AM in the latter half of the first century, particularly its 
utilization for clinical and therapeutic applications (John, 2003). In 1934 an Italian 
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physician used the AM as an epidermal lining for the creation of an artificial 
vagina in a patient with mullerian agenesis (Dua, Gomes, King, & Maharajan, 
2004; John, 2003; Brindeau, 1934; Nisolle & Donnez, 1992; Burger, 1937). The 
same physician would later use the AM in a more extensive construction of an 
artificial vagina (Dua, Gomes, King, & Maharajan, 2004; John, 2003; Brindeau, 
1934; Nisolle & Donnez, 1992; Burger, 1937). Also, in 1940 AM tissue was used 
to prevent meningo-cerebral adhesions after lacerations to the head, including 
gunshot wounds, depressed fracture of the skull, and craniotomy procedures 
(Chao, Humphreys, & Penfield, 1940). These studies showed a reduction in 
meningo-cerebral adhesions and were recommended for the use of adhesion 
prevention in other surgeries (Chao, Humphreys, & Penfield, 1940).  
The first research into clinical applications using the AM in the field of 
ophthalmology can be attributed to Dr. Rotth (Rotth, 1940). In 1940 Dr. Rotth 
replaced necrotic conjunctiva of a single eye with AM obtained from caesarian 
sections (Rotth, 1940). He believed the AM would be easily converted and 
tolerated once implanted since it was most similar to the conjunctiva membrane 
(Rotth, 1940). Although results of the experiment were ambiguous, Dr. Rotth 
encouraged further investigation (Rotth, 1940). Following, in 1946, Sorsby and 
Simmons replaced necrotic conjunctiva induced by caustic agents with human 
AM (Sorsby & Symons, Amniotic membrane grafts in caustic burns of the eye, 
1946). The clinical study entailed the replacement of conjunctiva in patients 
suffering from caustic burns of the eye with success (Sorsby & Symons, Amniotic 
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membrane grafts in caustic burns of the eye, 1946). However, further 
experiments using rabbits and lime as a caustic agent were unsuccessful 
(Sorsby, Haythorne, & Reed, 1947). Clinical and therapeutic application research 
of the AM in the field ophthalmology would not present itself again until 1993 
(Baradaran-Rafii, Aghayan, Arjmand, & Javadi, 2007; Dua, Gomes, King, & 
Maharajan, 2004; John, 2003).  
2.1.2.2 Identification of Amniotic Membrane Cells (1940s-1960s) 
Initial description of the cellular morphology of the AME can be attributed 
to Bautzmann and Schroder in 1955 (Benirschke, Kaufmann, & Baergen, 2006). 
Bautzmann and Schroder make reference to previous studies investigating 
properties of AM cells five to ten years prior to their investigation, which can 
technically be considered initial investigations on cellular morphology of the AM; 
however, these studies are in German without English translations and lacking 
abstracts. Bautzmann and Schroder’s initial investigations showed structural 
morphology of AME to be highly variable and composed of flat, cuboidal, and 
columnar cells (Benirschke, Kaufmann, & Baergen, 2006). In 1965 Thomas 
reported two morphologically distinct AME cell types based on ultrastructure 
differences reporting light and dark cell types (Benirschke, Kaufmann, & Baergen, 
2006; Thomas, 1965). Following, many studies investigating the morphological 
structure of the AME would show differences supporting both heterogeneous and 
homogeneous cell populations (Thomas, 1965). Studies supporting AM cell 
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heterogeneity include Armstrong et al. and Wynn and French in 1968 and 
McCoshen et al. 1981 (Benirschke, Kaufmann, & Baergen, 2006). Studies 
refuting such a presence include Lister et al. 1968, Sinha et al. 1971, Hempel et 
al. 1972, King et al. 1980, and Sonek et al. 1991 (Benirschke, Kaufmann, & 
Baergen, 2006). Interestingly, it was suggested that the heterogeneity of cell 
morphology was the product of inappropriate fixations, and method and 
technique differences (Benirschke, Kaufmann, & Baergen, 2006; Hoyes, Fine 
structure of human amniotic epithelium following short-term preservation in vitro., 
1972). Later in 2003, using enzymatic histochemistry, tracer permeability 
analysis, and freeze-substitution fixation, the controversial morphology of AME 
cells was concluded to be homogeneous (Iwasaki, Matsubara, Takizawa, 
Takayama, Yashiro, & Suzuki, 2003).   
2.1.2.3 Amniotic Membrane Investigation Reemergence (1970s-1990s) 
 The advent of newer techniques and methods for AM handling, processing, 
and preservation brought about heightened research in and a reemergence for 
clinical and therapeutic applications of the AM (Fetterolf & Snyder, 2012; Ward, 
Bennett, Burgos, & Fabre, 1989; Gruss & Jirsch, 1978). AM clinical and 
therapeutic application potentials inquiry reemerged in the 1970s with the 
reinvestigation of its application in wound healing and management (Gruss & 
Jirsch, 1978; Colocho, Graham, Greene, Matheson, & Lynch, 1974). Following 
were investigative studies in chronic venous leg ulcers and healing with AM 
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(Ward, Bennett, Burgos, & Fabre, 1989). Also, more invasive reconstructive 
studies of artificial vaginas were conducted (Nisolle & Donnez, 1992; Trancer , 
Katz, & Veridiano, 1979; Ashworth, Morton, Dewhurst, Lilford, & Bates, 1986; 
Dhall, 1984).  
 In 1987, scientists investigated the use of AM grafts to prevent post-
operative adhesions (Trelford-Sauder, Dawe, & Trelford, 1978). Application of 
AM grafts within the abdomen or intra-peritoneal cavity was shown to significantly 
reduce adhesion formation in animal models (Young, Cota, Zund, Mason, & 
Wheeler, 1991; Trelford-Sauder, Dawe, & Trelford, 1978). Optimum closure of 
large abdominal wall defects including gastroschisis and omphaloceles was 
largely controversial in the 1970’s (Seashore, MacNaughton, & Talbert, 1975; 
Gharib, Ure, & Klose, 1996). Over the course of several decades, and the 
utilization of various treatments and procedures to correct gastroschisis and 
omphaloceles, AM grafts were shown to increase closure of the wall defects 
(Gharib, Ure, & Klose, 1996; Rennekampff, Dohrmann, Fory, & Fandrich, 1994; 
Seashore, MacNaughton, & Talbert, 1975). 
 In 1992 a group of ophthalmological surgeons presented a series of 
studies to a large conference of ophthalmology specialists (Dua, Gomes, King, & 
Maharajan, 2004). Such studies revealed successful AM grafts in the treatment 
of several ocular disorders, and novel procurement procedures (Dua, Gomes, 
King, & Maharajan, 2004; John, 2003). Following, in 1995 Kim and Tseng, 
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influenced by the aforementioned study above, would set the stage and 
successfully reintroduce AM application investigations in ophthalmology 
(Baradaran-Rafii, Aghayan, Arjmand, & Javadi, 2007; Dua, Gomes, King, & 
Maharajan, 2004; John, 2003). The treatment of various ophthalmological 
diseases using AM had been optimized and utilized since the study by Kim & 
Tseng in 1995 (Baradaran-Rafii, Aghayan, Arjmand, & Javadi, 2007; Dua, 
Gomes, King, & Maharajan, 2004; John, 2003). These are discussed in detail in 
the translational development section below. Most importantly, the many 
biological properties of the AM that we currently know have come from the 
intensive study and research on AM clinical and therapeutic applications in 
ophthalmology during this reemergence period (Dua, Gomes, King, & Maharajan, 
2004; John, 2003).    
2.1.2.4 Identification of Amniotic Membrane Stem Cells (2000s-present) 
Stem cells of the AM can be placed into two categories: amniotic 
membrane epithelial stem cells (AM-ESC) and amniotic membrane 
mesenchymal stem cells (AM-MSC) (Dobreva, Pereira, Deprest, & Zwijsen, 2010; 
Miki, 2011). Prior to 2004, the isolation, and properties and characterization of 
stem cells within the membrane itself were largely unknown (Dobreva, Pereira, 
Deprest, & Zwijsen, 2010; Miki, 2011). The first indication that stem cells were 
present in the AM was in 2004 by Tamagawa et al., in which the authors claimed 
that cell lines from human AM contributed to all three germ layer formation in 
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xenogeneic mouse embryos mixed with embryonic stem cells (Miki, 2011; 
Dobreva, Pereira, Deprest, & Zwijsen, 2010). However, this study was unable to 
specify whether such a contribution and differentiation was due to that of AM-
ESC or AM-MSC (Miki, 2011).  
In 2005 AME cells were shown to differentiate into cells of all three germ 
layers further supporting a presence of stem cells specifically in the amniotic 
epithelial membrane, along with a subpopulation of amniotic epithelial cells 
expressing stem cell markers, supporting the characterization of AM-ESC 
(Dobreva, Pereira, Deprest, & Zwijsen, 2010; Miki, 2011). The first study initially 
characterizing AM-MSC is unclear (Miki, 2011; Dobreva, Pereira, Deprest, & 
Zwijsen, 2010). A study in 2007 done by Alviano et al. suggested that there was 
a presence of specific AM-MSC within the stromal layers of the AM by showing a 
immunophenotypical profile of AM mesenchymal cells most consistent with bone-
marrow mesenchymal stem cells (BM-MSC) (Dobreva, Pereira, Deprest, & 
Zwijsen, 2010). Further characterization and profiling of stem cells of AM-EMS 
and AM-MSC would occur following their initial characterization within their 
specific tissue layer and location (Dobreva, Pereira, Deprest, & Zwijsen, 2010). 
Translational developments, particularly therapeutic and clinical applications 
would be equally pursued, which would utilize the properties of AM-ESC and AM-
MSC (Dobreva, Pereira, Deprest, & Zwijsen, 2010).  These are discussed in the 
translation development section below. 
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2.2 Evolution 
The beginning of biological life took form in the vast oceans of a young 
earth (Miller, 1953). Over the span of hundreds of millions of years the evolution 
of complex, self-functioning cells derived from simple, self-replicating molecules 
paved the way for highly structured, sophisticated organisms (Miller, 1953). 
These organisms flourished in the deep blue ocean, constantly bathed and 
nourished by a maternal fluid (Miller, 1953). In time the evolution and 
development of land-dwelling animals emerged from aquatic life (Blackburn & 
Flemming, 2009; Leal & Ramirez-Pinilla, 2010; Pillai, 2012). The harsh 
environment of dry land called for adaptations suitable for life away from the 
nourishment of a ubiquitous fluid environment (Blackburn & Flemming, 2009) 
(Pillai, 2012). In particular, the sustainability and safety of the developing 
offspring was vitally important in the transition from aquatic to terrestrial life 
(Blackburn & Flemming, 2009). It was the evolution of a protective egg, the 
amniotic egg, roughly 340 million years ago that allowed this transition (Pillai, 
2012). 
Amniotes, as defined by evolutionary biologists, are land-dwelling 
tetrapods that produce offspring eggs, or amniotic eggs in which the embryo 
develops (Pillai, 2012; Leal & Ramirez-Pinilla, 2010). Amniotes envelop several 
phylogenic classes including Reptilia, Aves, Mammalia, and their fossil ancestors, 
dinosaurs (Pillai, 2012; Leal & Ramirez-Pinilla, 2010; Blackburn & Flemming, 
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2009). Within the amniote classification exist egg-laying, oviparous tetrapods, 
including reptiles, birds, early mammals, and fossil ancestors; and egg-bearing, 
viviparous tetrapods that includes late mammals (Pillai, 2012; Leal & Ramirez-
Pinilla, 2010; Blackburn & Flemming, 2009). Some exceptions do exist regarding 
this classification but are beyond the scope of this paper (Pillai, 2012).  
Characteristic of the amniotic egg is four extra-embryonic membranes 
(Pillai, 2012; Blackburn & Flemming, 2009). These extra-embryonic membranes 
include the CM, allantois, yolk sac, and the AM (Pillai, 2012; Blackburn & 
Flemming, 2009). The CM is the thickest, outer-most extra-embryonic membrane 
responsible for gas exchange (Pillai, 2012; Blackburn & Flemming, 2009; Larsen, 
1997). The allantois grows out of the hindgut and stores and disposes of 
nitrogenous waste (Pillai, 2012; Blackburn & Flemming, 2009; Larsen, 1997). 
The yolk sac develops from the mid-gut, and provides the necessary nutrients for 
the developing organism (Pillai, 2012; Blackburn & Flemming, 2009; Larsen, 
1997).  Of the extra-embryonic membranes, it is the AM that is most intimate with 
the developing embryo and fetus, encasing the embryo and fetus in AF 
(Blackburn & Flemming, 2009; Larsen, 1997). Over the course of amniote 
evolution the functions and structure of these extra-embryonic membranes would 
differ with the progress of new amniote species (Pillai, 2012; Leal & Ramirez-
Pinilla, 2010; Blackburn & Flemming, 2009). More fit and efficient reproductive 
strategies would drive such evolution of the amniotic egg (Pillai, 2012; Leal & 
Ramirez-Pinilla, 2010; Blackburn & Flemming, 2009). Unfortunately, the 
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understanding and knowledge of the diversity and evolution of amniote’s extra-
embryonic membranes is extremely limited with much of our understanding 
coming from research of extra-embryonic membranes done on repitles (Leal & 
Ramirez-Pinilla, 2010; Blackburn & Flemming, 2009). 
The first amniotic eggs were of oviparous tetrapods, and contained a 
hardened, calcareous shell that prevented egg desiccation, and provided 
protection for the delicate extra-embryonic membranes and developing embryo 
(Leal & Ramirez-Pinilla, 2010; Blackburn & Flemming, 2009). Primitive amniotic 
eggs relied exclusively on the yolk sac for nutrition (Pillai, 2012; Leal & Ramirez-
Pinilla, 2010; Blackburn & Flemming, 2009). In more evolved amniotes, the yolk 
sac serves a lesser purpose, and is less developed in placenta (placentotrophic) 
amniotes, in which the placenta provides nutrients (Pillai, 2012; Blackburn & 
Flemming, 2009). An umbilical cord serves as a conduit between the fetus and 
placenta (Pillai, 2012; Larsen, 1997). The umbilical cord is a specialized tissue 
composed of the AM, CM, yolk sac, and allantois (Pillai, 2012; Larsen, 1997). 
This specialized tissue is discussed in more detail in the embryology section 
below. The allantois is the last extra-embryonic membrane to develop of the four 
fetal extra-embryonic membranes (Pillai, 2012; Larsen, 1997). The allantois 
develops complementary to the amnion (Pillai, 2012; Larsen, 1997). In oviparous 
amniotes the allantois grows into the chorionic cavity, serving as a site of 
nitrogenous waste disposal (Pillai, 2012; Blackburn & Flemming, 2009). In more 
evolved amniotes, the allantois fuses with CM to produce a single membrane, in 
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which the allantois plays a major role in gas exchange (Pillai, 2012; Blackburn & 
Flemming, 2009; Larsen, 1997). The transition of amniotes from oviparous to 
viviparous, or the fusion of membranes to create more complex tissues is unclear 
but is believed to be the result of more specialization of the extra-embryonic 
membranes (Pillai, 2012; Leal & Ramirez-Pinilla, 2010; Blackburn & Flemming, 
2009).  
It is important to note the enormous diversity of amniotes compared to 
non-amniotes, or an-amniotes (Pillai, 2012). Such diversity is seen in the size, 
structure, and function of amniotes (Pillai, 2012). The specialized functions of the 
extra-embryonic membranes found in the amniotic egg have served more than 
physiological and protective purposes and have brought about great diversity of 
species over hundreds of millions of years (Pillai, 2012; Blackburn & Flemming, 
2009). There is a large gap in the knowledge in the biology of this evolutionary 
diversity (Pillai, 2012). Function of the AM of the amniotic egg has remained 
constant throughout its evolution hundreds of millions of years ago (Pillai, 2012; 
Leal & Ramirez-Pinilla, 2010; Blackburn & Flemming, 2009). It serves to protect 
the developing embryo and fetus from physical disturbances, and maintains a 
constant internal fluid, and nourishing environment for the developing embryo 
and fetus (Pillai, 2012; Blackburn & Flemming, 2009).  
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2.3 Embryology 
The AM, or amnion derives from primary ectoderm, also known as epiblast 
or ectoblast cells, of the bilaminar germ disc present in the second week of 
gestation in humans (Larsen, 1997). The aforementioned bilaminar germ disc is 
part of the inner cell mass that composes part of the developing blastocyst 
(Larsen, 1997). Upon implantation of the blastocyst into the wall of the mother’s 
uterus, the inner cell mass of the blastocyst differentiates into two cellular layers: 
a dorsal layer of columnar cells, the primary ectoderm, mentioned above; and a 
ventral layer of cuboidal cells, the primary endoderm, also known as the 
hypoblast or endoblast cell layer (Larsen, 1997). These two primary layers of 
cells are called the embryoblast, or embryonic disc, and makeup all tissues of the 
developing embryo (Larsen, 1997).  
On day 8 post-fertilization, epiblast cells begin excreting a fluid, producing 
a cavity, the pro-amniotic cavity, within, or a hollowing out of the epiblast layer 
(Larsen, 1997). This cavity is the beginning of the amniotic cavity (Larsen, 1997). 
As the cavity begins to grow via epiblast proliferation, cavitation of proliferating 
cells and apical excretion, a layer of ventral epiblast cells differentiates into a thin 
membrane separating the now amniotic cavity from the adjacent, more ventral 
cytotrophoblast (Larsen, 1997). These specialized epiblast cells, amnioblasts, 
are derived from the proximal-anterior epiblast cells of the newly formed 
bilaminar germ disc, prior to the pre-streak and primitive streak stages (Larsen, 
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1997). Epiblast cells adjacent and ventral to the hypoblast but not bordering the 
cytotrophoblast, and continuous with the amnioblasts, are to become the 
intraembryonic ectoderm and mesoderm of the three-layered germ disc in week 
five of gestation (Larsen, 1997). These differentiated, specialized cells now 
known as amnioblasts makeup the inner layer of the AM and create AF during 
early human embryo development (Larsen, 1997). Production and composition of 
AF is a function of amnioblasts and are discussed in the AF volume and 
regulation, and composition sections of this thesis. 
On day 9 post-fertilization, as the epiblast proliferates and cells are 
displaced by a growing amniotic cavity, the cells of the primary endoderm 
(hypoblast) simultaneously proliferate and line the blastocyst cavity, adjacent to 
the developing trophoblast, creating the exocoelomic membrane, or Heuser’s 
membrane (Larsen, 1997). These cells differentiate into flattened, squamous 
cells by day 12 post-fertilization, completely lining the once blastocoele, and 
define the primary yolk sac or exocoelomic cavity (Larsen, 1997). These cells are 
now considered extraembryonic endoderm, and are continuous with the 
differentiating hypoblast at the embryonic pole (Larsen, 1997).  
Appearing between days 12 and 13 post-fertilization is a thick, loose 
reticular acellular layer called the extraembryonic reticulum (magma reticulare) 
that forms between the extraembryonic endoderm and adjacent cytotrophoblast 
(Larsen, 1997). Within the extraembryonic reticulum are growing lacunae (Larsen, 
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1997). These lacunae grow, accumulate and coalesce, forming the 
extraembryonic coelom, also known as the chorionic cavity (Larsen, 1997). As 
the chorionic cavity grows in size, the primitive yolk sac is pinched ventrally and 
becomes the exocoelomic cyst (Larsen, 1997). The new dorsal part of the 
primary yolk sac becomes the definitive yolk sac (Larsen, 1997). It is believed 
that the extraembryonic mesodermal tissue lining the extraembryonic coelom is 
derived from proliferating and migrating posterior and posterolateral epiblast cells 
of the embryoblast (Larsen, 1997). The inner lining of the extraembryonic coelom 
is the extraembryonic mesoderm known as extraembryonic splanchnopleuric 
mesoderm, which is adjacent to the endoderm of the newly established definitive, 
secondary yolk sac and the AM (Larsen, 1997). It is believed that the endodermal 
cells lining the newly established definitive, secondary yolk sac is derived from 
newly proliferating and differentiated cells of the hypoblast, different from the 
cells of Heuser’s membrane although the same site of origin (Larsen, 1997). A 
small diverticulum forms at the posterior part of the secondary yolk sac and 
extends into the body stalk; this is the beginning of the developing allantois 
(Larsen, 1997). 
The outer layer of the extraembryonic mesoderm, also called the 
extraembryonic somatoplueric mesoderm lines the inner layer of the 
cytotrophoblast and is considered the chorionic membrane (Larsen, 1997). 
Suspended in the newly formed extraembryonic coelom are the amniotic cavity, 
embryoblast, and definitive yolk sac, and bordered by the extraembryonic 
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splanchnopleuric mesoderm (Larsen, 1997). It is the connecting/body stalk of 
extraembryonic mesoderm that connects these developing structures with the 
developing extraembryonic trophoblast (Larsen, 1997). As the extraembryonic 
coelom grows larger in size, lacunae part the connecting stalk and thus separate 
the developing embryo and amnion from the extraembryonic trophoblast (Larsen, 
1997).  
Throughout gestation the amniotic and chorionic cavities grow in size 
(Larsen, 1997). However, as pregnancy progresses the relative size of the 
amniotic cavity will grow larger in ratio to that of the chorionic cavity (Larsen, 
1997). As the suspended amniotic sac and embryo grow within the chorionic 
cavity, the volume of the extraembryonic coelom decreases in size, and the AM 
with the inner membrane of the chorion (extraembryonic mesoderm/reticulum) 
eventually fuses (Larsen, 1997). The AM is believed to completely fuse with the 
inner CM by the 12th week of gestation (Larsen, 1997). The fusion of the AM and 
CM represent an intimate association of membranes than the actual histological 
fusion of two membrane entities, as indicated by the easy separation of the two 
membranes (Larsen, 1997). 
The umbilical cord, an organ found in placentotrophic, vivoparous 
mammals including humans, mentioned above in the evolution of the AM, is a 
specialization of the secondary yolk sac, allantois, and connecting/body stalk of 
the extraembryonic mesoderm (Pillai, 2012; Larsen, 1997; Blackburn & 
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Flemming, 2009). The allantois is an out-pouching of the hindgut composed of 
extraembryonic somatoplueric mesoderm that expands into the chorionic, 
extraembryonic mesoderm of the connecting/body stalk (Pillai, 2012; Larsen, 
1997). The extraembryonic somatoplueric mesoderm of the developing allantois 
fuses with the extraembryonic splanchnopleuric mesoderm of the primitive 
chorionic connecting/body stalk, creating the chorio-allantoic membrane (Pillai, 
2012; Larsen, 1997). Upon fusion of the allantois membrane and primitive CM, 
the extraembryonic mesoderm of the body stalk becomes heavily vascularized 
(Pillai, 2012; Larsen, 1997). Developing from this heavy vascularization are the 
vascular conduits of the primitive umbilical cord (Pillai, 2012; Larsen, 1997).  
Lining the developing umbilical cord is the AM that expands and fuses with 
the chorion proper in the 12th week of gestation (Larsen, 1997). However, prior 
to complete fusion with the chorionic proper, the AM and cavity expand and fold 
within the chorionic cavity (Larsen, 1997). The expanding AM first fuses with the 
chorionic extraembryonic mesoderm of the primitive umbilical cord closest to the 
developing embryo (Larsen, 1997). As gestation progresses, the AM grows 
outward, fusing dorsally with the umbilical cord until it completely closes and 
fuses with the chorionic proper (Larsen, 1997).  
2.4 Structure: Histology and Immunohistochemistry 
Upon microscopic examination of the AM, five distinct principal layers are 
revealed (John, 2003; Bourne, 1962). The first layer is a simple epithelial layer 
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that is in direct contact with the AF, also known as the AME (John, 2003; Bourne, 
1962). The second layer is the BM, which lies between the AME layer and 
compact layer (John, 2003; Bourne, 1962). BM is a continuous connective tissue 
stroma that is divided into three layers, third through fifth, which is intimate with 
connective tissue of the chorionic membrane (John, 2003; Bourne, 1962). The 
third through fifth layers include the compact layer, fibroblast layer, and spongy 
layer, respectively (John, 2003; Bourne, 1962). 
The extent and thickness of these layers vary depending on the location of 
the AM (van Herendael, Oberti, & Brosens, 1978). Three distinct sections of the 
AM exist: the amniotic reflectum, umbilical amnion, and placental amnion (van 
Herendael, Oberti, & Brosens, 1978). It is the five layers of the amniotic reflectum 
that will be discussed in detail for it is this structural section of the AM that is 
most referenced and studied (van Herendael, Oberti, & Brosens, 1978). Slight 
variations of these layers do exist among the placental amnion and umbilicus 
amnion and are discussed accordingly (van Herendael, Oberti, & Brosens, 1978). 
Also, the immunohistochemistry of each layer is described to provide a more 
detailed analysis of the structure of such layers.  
Temporally, the cellular morphology of the AM changes, but is relatively 
constant from about the fourth month of gestation until birth (Benirschke, 
Kaufmann, & Baergen, 2006; Pollard, Aye, & Symonds, 1976). Much of the 
literature on the structure and morphology of the amniotic membrane is limited to 
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the amniotic reflectum of term births (van Herendael, Oberti, & Brosens, 1978). 
The structure of the AM throughout gestation is briefly discussed with reference 
to the AM lining the umbilical cord, umbilical amnion, and AM lining the chorionic 
leave of the placenta, placental amnion (van Herendael, Oberti, & Brosens, 
1978).  
2.4.1 Amnion Reflectum 
2.4.1.1 Epithelial Layer 
Light microscopy of delivered term AM reflectum epithelial reveals 
consistent, homologous staining cells with moderately staining, centrally located 
nuclei (Bourne, 1962). Epithelial of the amniotic reflectum ranges in 
morphological shape from cuboidal to columnar (Benirschke, Kaufmann, & 
Baergen, 2006). Columnar cells appear where the AM reflectum inserts into the 
placental margin (Benirschke, Kaufmann, & Baergen, 2006). It is important to 
note that AM derived from caesarian sections show an AME layer of cells that 
are uniformly cuboidal in shape compared to the greater diversity in 
morphological shape found in AM of normal, labor deliveries (Thomas, 1965). 
The apical surface, intimate with the AF, is convex in shape (Bourne, 1962). A 
more detailed description is given by EM. Also, thickness of the AME ranges 
from 18-56m depending on location of the AM with thickness being greatest at 
the umbilicus closest to the fetus (Benirschke, Kaufmann, & Baergen, 2006).  
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 Ultrastructure examination by Thomas revealed two different cell types of 
AME: light and dark cell types (Thomas, 1965). It was therefore suggested that 
light and dark cell types had different roles as AME cells. The first is the “Golgi 
Type” dark cell type (Thomas, 1965). Ultrastructurally, the “Golgi type” cell type 
has mitochondrial distributed throughout the cell preferably around the nucleus 
and towards the basal side (Thomas, 1965). There are significant amounts of 
lipid granules that are ubiquitous throughout the cell (Thomas, 1965). The 
strongest feature of this cell type is an extensive and widely distributed Golgi 
apparatus, and apparent rough and smooth endoplasmic reticula, suggesting a 
large secretory role of this cell type (Thomas, 1965). Also, complex foot 
processes are found at the basal surface of this cell type (Thomas, 1965). The 
second cell type is the “Fibrillar Type” light cell type61. According to Thomas, this 
cell type is denser in appearance than the “Golgi Type” cell with dense fibrils 
arranged in random orientation within the cell (Thomas, 1965). There is a smaller 
concentration and dispersion of mitochondria, Golgi apparatus, and endoplasmic 
reticulum suggesting a less important secretory role than that of the “Golgi Type” 
cell (Thomas, 1965). Cell types described by Thomas revealed a heterogeneous 
mixture of cell types of AME (Thomas, 1965). Following Thomas’s results, 
studies would support or refute such findings (Benirschke, Kaufmann, & Baergen, 
2006; Hoyes, Fine structure of human amniotic epithelium following short-term 
preservation in vitro., 1972). More specifically, Lister et al. described the 
ultrastructure of a single, homogeneous AME layer scarce of apical microvilli, 
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complex intercellular microvilli with desmosomes, large nuclei, abundant 
glycogen, and infrequent mitochondria, endoplasmic reticulum, and Golgi 
lamellae (Benirschke, Kaufmann, & Baergen, 2006). These similarities represent 
universal morphological structure features of these cells, which are discussed 
below.   
EM reveals an ultrastructure of the AME to have numerous microvilli 
structures on the apical end of the epithelial cells (Benirschke, Kaufmann, & 
Baergen, 2006; Sinha, 1971). These microvilli are of a short, blunt, and simple 
branched type (Sinha, 1971). They have a surface with a densely packed 
glycocalyx (Benirschke, Kaufmann, & Baergen, 2006). Morphology of the 
microvilli is identical of both cell types mentioned above: “Golgi Type” and 
“Fibrillar Type cell types (Thomas, 1965). Also, microvilli are found to continue 
down the lateral side of AME cells and form intercellular channels (van 
Herendael, Oberti, & Brosens, 1978). 
AME nuclei are centrally located, and are irregular in shape with 
fenestrations (Bourne, 1962). Vacuoles are apparent within the cytoplasm 
(Bourne, 1962). These vacuoles are most prevalent at the lateral portions of AME, 
and with limited vacuoles present in the apical, microvilli portion of the cell 
(Bourne, 1962). Also, there is a large presence of vacuoles closely associated 
with the nucleus of the cell (van Herendael, Oberti, & Brosens, 1978). These 
vacuoles have been shown to contain lipid substances (van Herendael, Oberti, & 
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Brosens, 1978). Some vacuoles of adjacent cells appear to be connected via fine 
channels (Bourne, 1962). Channels and canals are believed to be part of a large, 
extensive communication system between cells of the AME (Bourne, 1962). 
Numerous desmosomes can be found between adjacent AME cells in which the 
vast arrays of filaments within the cytoplasm are connected (Bourne, 1962).  
AME cells have been shown to express CA-1, CA-2, and CA-125, 
peptidase dipeptigylpeptidase IV, HLA class I molecules, EGF receptors, TGF-1, 
TGF-2, TGF-3, and their type I and II receptors, CD44 (HA receptor), desmin, 
oxytocin receptors, erythropoietin and erythropoietin receptors; but do not 
express HLA class II molecules (Mamede, Carvalho, Abrantes, Laranjo, Maia, & 
Botelho, 2012; Dua, Gomes, King, & Maharajan, 2004). These cells can be 
induced to express ICAM-1, TNF-, and IL-1 (Mamede, Carvalho, Abrantes, 
Laranjo, Maia, & Botelho, 2012; Dua, Gomes, King, & Maharajan, 2004). 
Immunohistochemistry of the cytoskeleton of AME cells reveals the 
expression of various cytoskeleton proteins (Wolf, Schmidt, & Drenckhahn, 1991). 
Distributed preferentially toward apical and lateral surfaces of AME cells include 
actin, -actinin, spectrin, and ezrin (Wolf, Schmidt, & Drenckhahn, 1991). 
However, distributed universally throughout AME cells’ cytoplasm is the protein 
vimentin (Wolf, Schmidt, & Drenckhahn, 1991). The architecture of the 
cytoplasm’s cytoskeleton and various lateral cellular junctions are believed to 
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play an important role in diffusion between maternal circulation and AF (Wolf, 
Schmidt, & Drenckhahn, 1991).  
2.4.1.2 Basement Membrane 
 Light microscopy (LM) of the BM reveals very little due to the inherent 
nature of its small size. For this reason EM and immunohistochemistry are 
required to assess the BM in more detail.  
AME cells are attached to a thick BM (Benirschke, Kaufmann, & Baergen, 
2006). This BM is considered to be the thickest of all BM found in human tissues 
(Benirschke, Kaufmann, & Baergen, 2006).  A typical BM is composed of a basal 
lamina and lamina reticularis, which can be discerned using EM (Aplin, Campbell, 
& Allen, 1985). More specifically, the basal lamina is composed of two distinct 
layers, the lamina lucida and the lamina densa (Aplin, Campbell, & Allen, 1985). 
Ultrastructure examination of the AM BM reveals three different layers of varying 
size fibrils (Bourne, 1962). The first layer closest to the AME layer is composed 
of a network of delicate, parallel fibers of type IV collagen (Aplin, Campbell, & 
Allen, 1985; Bourne, 1962). This layer most likely represents the delicate fiber 
type found in the lamina lucida of most basal laminae (Aplin, Campbell, & Allen, 
1985). This fibrous network runs from the lamina densa to the basal cell surface 
of the AME (Aplin, Campbell, & Allen, 1985). This layer is most consistent with 
the lamina lucida of the BM (Aplin, Campbell, & Allen, 1985; Thomas, 1965). 
Below, the second layer is composed of a looser network of larger fibers of the 
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reticular and collagen types (Aplin, Campbell, & Allen, 1985; Thomas, 1965). The 
second layer is consistent with the lamina densa of the BM (Aplin, Campbell, & 
Allen, 1985; Thomas, 1965). The third layer of the BM, is composed of large 
collagen fibers arranged in random orientation (Thomas, 1965; Bourne, 1962). It 
is not clear if this third layer is a continuation of the second BM layer, lamina 
lucida, or is in fact the lamina reticularis of the BM (Thomas, 1965; Bourne, 1962). 
Collagen type I, and fibronectin are found in all layers of the BM (Aplin, Campbell, 
& Allen, 1985).    
 Large amounts of proteoglycans with heparin sulfate, collagen types I, III, 
IV, V, and VII, laminin, and fibronectin can be found in the BM (Dua, Gomes, 
King, & Maharajan, 2004). Hemidesmosomes can be found associated with the 
first layer of the BM, the lamina lucida, and attached to the basal surface of AME 
cells (Dua, Gomes, King, & Maharajan, 2004). Integrins that make up such 
hemidesmosomes include 64, and B-1 integrins (Dua, Gomes, King, & 
Maharajan, 2004). 
2.4.1.3 Compact Layer 
 The first layer of the AM mesenchymal stroma is the compact layer (Dua, 
Gomes, King, & Maharajan, 2004). This layer is avascular and devoid of cells 
(Mamede, Carvalho, Abrantes, Laranjo, Maia, & Botelho, 2012; Dua, Gomes, 
King, & Maharajan, 2004; Bourne, 1962). It is believed that the compact layer is 
the strongest of all 5 layers, and is responsible for maintaining the tensile and 
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mechanical properties of the AM (Mamede, Carvalho, Abrantes, Laranjo, Maia, & 
Botelho, 2012). It is the arrangement of collagen fibers and size that is believed 
to give such tensile properties to the AM not elastin, which is scare in the AM 
(Baradaran-Rafii, Aghayan, Arjmand, & Javadi, 2007). 
 EM of the compact layer of the AM reveals a dense packing of collagen 
fibers (Aplin, Campbell, & Allen, 1985). A transition zone can be seen within the 
compact layer (Aplin, Campbell, & Allen, 1985). Above the transition zone, 
closets to the BM, is a tightly packed network of fibers; however, they are small in 
diameter (Aplin, Campbell, & Allen, 1985). Below the transition zone is a thicker 
class of fibers but are less tightly packed than fibers above the transition zone 
(Aplin, Campbell, & Allen, 1985). These fibers found in the compact layer are 
prominently composed of collagen type I and III fibers (Bourne, 1962). Also, 
small amounts of parallel bundles of collagen types II, IV and V can be found in 
the compact layer (Aplin, Campbell, & Allen, 1985). Thickness of the compact 
layer ranges from 5-20m (Bourne, 1962). It has been suggested that this layer, 
rich in collagen type III fibers (reticular fibers) is a large lamina reticularis, a 
continuation of the thick BM of the AM (Ockleford, et al., 1993). It is possible that 
this layer represents, or is a continuation of the third layer of the BM mentioned 
above (Thomas, 1965; Bourne, 1962; Ockleford, et al., 1993). Synthesis of 
collagen types I, III, and IV; and laminin and fibronectin by AME cells makes up 
the fibers that create their BM (Aplin, Campbell, & Allen, 1985). They create the 
fibers that make up the BM of the AM and compact layer suggesting that the 
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compact layer is indeed a unique large lamina reticularis of the BM of the AM 
(Ockleford, et al., 1993).  
 Several fibronectin isoforms can be found in the compact layer of the AM, 
which are secreted by AME cells (Benirschke, Kaufmann, & Baergen, 2006). 
These molecules compose part of the meshwork in which the dense collagen 
type III fibers of the compact layer are found (Campbell, Allen, Moser, & Aplin, 
1989).   
2.4.1.4 Fibroblast Layer 
 Below the compact layer is the fibroblast layer (John, 2003; Bourne, 1962). 
This layer is the thickest of the 5 layers of the AM (Benirschke, Kaufmann, & 
Baergen, 2006).  This layer is composed of a collagen matrix, reticular fibers and 
branched fibroblast-like mesenchymal cells also referred to as AM mesenchymal 
cells (Baradaran-Rafii, Aghayan, Arjmand, & Javadi, 2007). This layer is 
avascular (Mamede, Carvalho, Abrantes, Laranjo, Maia, & Botelho, 2012). Cells 
of the AM mesenchymal stroma derive nutrients through diffusion from AF on 
one side and the vascular CM on the opposite side (Mamede, Carvalho, 
Abrantes, Laranjo, Maia, & Botelho, 2012; Benirschke, Kaufmann, & Baergen, 
2006).  
 It is this large array of reticular fibers found in the fibroblast layer that gives 
the AM great elasticity (Mamede, Carvalho, Abrantes, Laranjo, Maia, & Botelho, 
2012). No tight junctions can be found between branched fibroblast cells within 
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this layer (Bou-Resli, Al-Zaid, & Ibrahim, 1981). Also, macrophages or Hofbauer 
cells can be found scarcely throughout this layer and the spongy layer below 
(Bourne, 1962). Ultrastructure examination of fibroblast cells reveals a single 
nucleus with varying diameter and eccentrically located, a foamy or vacuolated 
cytoplasm (Bourne, 1962). Pseudopodia can be seen occasionally suggesting 
active phagocytic events (Bourne, 1962). The cell itself is oval to round in shape 
(Bourne, 1962). They have been shown to contain large quantities of meconium 
in their vacuoles (Bourne, 1962).  
Characterization of AM mesenchymal stroma cells is defined by fibroblast-
like cell morphology are positive for cell surface markers CD13, CD29, CD44, 
CD54, CD73, CD105, and CD166 (Toda, Okabe, Yoshida, & Nikaido, 2007).  
2.4.1.5 Spongy Layer 
 Adjacent to the fibroblast layer of the AM is the spongy layer (Benirschke, 
Kaufmann, & Baergen, 2006). This layer is considered to be the transition or 
intermediate between the AM and CM (Benirschke, Kaufmann, & Baergen, 2006). 
The spongy layer is largely composed of hydrated proteoglycans and 
glycoproteins, and non-fibrillar type III collagen (reticular fibers) (Benirschke, 
Kaufmann, & Baergen, 2006; Bourne, 1962). Collagen of the reticular type is 
present in wavy bundles (Bourne, 1962). This layer varies in thickness due to 
absorptive properties due to the heavy presence of proteoglycans and 
glycoproteins, and allows movable properties that do restrict AM attachment to 
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the CM allowing sliding against the CM (Benirschke, Kaufmann, & Baergen, 
2006). Below the spongy layer is the mesenchymal stroma, or connective tissue 
of the CM (Benirschke, Kaufmann, & Baergen, 2006). Here we find a reticular 
layer that contains CM mesenchymal cells that have been shown to resemble 
hematopoietic progenitor cells (Benirschke, Kaufmann, & Baergen, 2006). This 
layer is avascular in the first trimester but becomes vascularized in the beginning 
of the second trimester (Mamede, Carvalho, Abrantes, Laranjo, Maia, & Botelho, 
2012; Benirschke, Kaufmann, & Baergen, 2006). Occasional fibroblast and 
macrophages, described above are found within the spongy layer (Bourne, 1962). 
Collagen types I and IV can also be found in this layer (Niknejad, Peirovi, Jorjani, 
Ahmadiani, Ghanavi, & Seifalian, 2008).  
 The ultrastructure of the spongy layer of the AM reveals a unique 
geometry of the reticular fibers as being branched with triangular shaped nodes 
at the junctions (Bourne, 1962). These fibers are also loosely arranged separated 
by a system of clefts believed to be the remainder of the once large exocoel 
(Benirschke, Kaufmann, & Baergen, 2006).  
2.4.2 Umbilical Amnion 
The structural morphology of the AME lining the umbilical cord varies by 
location and with gestational age (Hoyes, Ultrastructure of the epithelium of the 
human umbilical cord., 1969). Between 8 and 10 weeks of gestation the AME of 
the umbilical cord is a single layer of squamous cell (Hoyes, Ultrastructure of the 
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epithelium of the human umbilical cord., 1969). At about 10 to 15 weeks of 
gestation the amniotic epithelial of the umbilicus is bilaminar (Hoyes, 
Ultrastructure of the epithelium of the human umbilical cord., 1969). The later 
part of the 5th month, including the sixth and 7th months of pregnancy, three or 
more layers can be found, increasing in number with gestational age (Hoyes, 
Ultrastructure of the epithelium of the human umbilical cord., 1969). Some parts 
of the AME of the umbilicus are four or five layers thick (Hoyes, Ultrastructure of 
the epithelium of the human umbilical cord., 1969). Lower layers of the stratified 
epithelium stain darker than top layers (Hoyes, Ultrastructure of the epithelium of 
the human umbilical cord., 1969).  
The progression and differentiation of the AM that lines the umbilical cord 
is similar to that of the fetal epidermis; however, there is no evidence of definitive 
keratinization in the majority of squamous epithelial of the umbilicus AM (Hoyes, 
Ultrastructure of the epithelium of the human umbilical cord., 1969). However, 
keratinization has been found of the squamous epithelia of the umbilical cord AM 
closest to the fetus (Hoyes, Ultrastructure of the epithelium of the human 
umbilical cord., 1969).  
Ultrastructurally, organelles and glycogen are apparent in the apical 
cytoplasm of the superficial cells from week 11 to 26 of gestation (Hoyes, 
Ultrastructure of the epithelium of the human umbilical cord., 1969). These 
findings indicate a secretory role of AME of the umbilical cord within these weeks 
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(11-26) (Sinha, 1971). These cells contain relatively few microvilli, and there are 
few villous folds of the AME (Sinha, 1971). However, cilia are present on the 
apical cell surface of AME cells (Hoyes, Ultrastructure of the epithelium of the 
human umbilical cord., 1969).  
2.4.3 Placental Amnion 
 AME cells lining the placental CM are cylindrical in shape (van Herendael, 
Oberti, & Brosens, 1978). Microvilli of the placental AM are shown to be 
interwoven among adjacent apical cells (van Herendael, Oberti, & Brosens, 
1978). The nuclei of these AME cells are located closer to the apical portion of 
the cells compared to AME cells of the amniotic reflectum, which are centrally 
located (van Herendael, Oberti, & Brosens, 1978). BM foot processes are 
prominent of the placental AME (van Herendael, Oberti, & Brosens, 1978).  
2.5 Functions and Properties 
The AM is more than a simple, static membrane (Benirschke, Kaufmann, 
& Baergen, 2006). It serves not only as a physical barrier, but protects the 
delicate fetus from physical trauma, and is metabolically and physiologically 
active both preventing desiccation of the fetus, and maintaining a dynamic, living 
solution in which the fetus develops (Benirschke, Kaufmann, & Baergen, 2006). 
The many properties of the AM unraveled from decades of research have given 
new promises in various medical fields through translational developments, 
mainly clinical and therapeutic applications (Mamede, Carvalho, Abrantes, 
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Laranjo, Maia, & Botelho, 2012; Toda, Okabe, Yoshida, & Nikaido, 2007; Dua, 
Gomes, King, & Maharajan, 2004). The discovery of many of these properties 
can be most attributed to research done in ophthalmology wishing to utilize the 
AM for optical diseases and disorders done over the past two decades (Dua, 
Gomes, King, & Maharajan, 2004). These properties are discussed below.   
2.5.1 Physical Properties 
The AM is a membrane of great strength (Benirschke, Kaufmann, & 
Baergen, 2006). Given its relative thickness the AM is able to withstand great 
trauma, including shear force and stretching (Benirschke, Kaufmann, & Baergen, 
2006). These properties are inherent within the histological make-up of the 
membrane (Benirschke, Kaufmann, & Baergen, 2006; Lavery, Miller, & Johns, 
1980; Wyatt-Ashmead & Ashmead, 2004). The average tensile strength of the 
AM is 2-5 g/cm with a range of 50-500 g/cm (Lavery, Miller, & Johns, 1980). The 
tensile strength of the AM is greater than that of the CM (Wyatt-Ashmead & 
Ashmead, 2004). Also, the AM tensile strength is greatest during early gestation 
and decreases towards term; however, the tensile strength of the AM at term is 
greater than that required for successful parturition (Wyatt-Ashmead & Ashmead, 
2004).  
2.5.2 Immunological 
It was suggested by Talmi et al. that the AM contained no inherent anti-
microbial properties but such properties exhibited by the membrane were due to 
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the membrane’s ability to adhere firmly and sound to substances and thus 
prevent penetration by bacteria and infection (Dua, Gomes, King, & Maharajan, 
2004). Research investigating the antiviral properties of the AM is limited. It is 
known that the AM contains the protein cystatin E, a proteinase inhibitor 
analogous to cysteine proteinase inhibitor with known antiviral properties 
(Baradaran-Rafii, Aghayan, Arjmand, & Javadi, 2007). Also, studies have shown 
interferon (IFN) synthesis and secretion by amniotic epithelial cells in quantities 
similar to immune leukocytes and skin fibroblasts with substantial anti-viral 
effects (Ferreira, de la Rogue, Rumjanek, & Golgher, 1992).  
AME cells have been shown to inhibit proteinase activity, and inhibit 
infiltration and chemotactic activity of polymorphonuclear leukocytes and 
macrophages (Hori, Wang, Kamiya, Takahashi, & Sakuragawa, 2006). AME cells 
have also been shown to reduce proliferation of T and B cells, and suppress 
interleukin activity of IL-1 and IL-1 (Hori, Wang, Kamiya, Takahashi, & 
Sakuragawa, 2006). However, AME cells can be induced to express a pro-
inflammatory molecule ICAM-1, a facilitating leukocyte adhesion and homing 
molecule and thus plays an important role in inflammation, by TNF-α and IL-1β 
(Dua, Gomes, King, & Maharajan, 2004). The stroma of the AM has been shown 
to effectively suppress inflammation by the inhibition of IL-1α and IL-1β 
(Fernandes, Mittanamalli, Sangwan, & Rao, 2005). Also, the secretion of TIMP-1, 
-2, -3, and -4 by AME cells further supports an ant-inflammatory role/property of 
the AM (Baradaran-Rafii, Aghayan, Arjmand, & Javadi, 2007). 
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Initially, it was believed that amniotic epithelia cells did not express Human 
Leukocyte Antigen (HLA) molecules because amniotic membrane grafts were not 
rejected post transplantation (Hori, Wang, Kamiya, Takahashi, & Sakuragawa, 
2006; Dua, Gomes, King, & Maharajan, 2004). This includes the lack of 
expression of HLA-A, -B, -D, and –DR antigens or β2-microglobulin on their cell 
surface (Hori, Wang, Kamiya, Takahashi, & Sakuragawa, 2006; Dua, Gomes, 
King, & Maharajan, 2004). Although initial studies using AM as transplant grafts 
suggested that AME cells did not express HLA molecules, it was shown that 
these HLA class I molecules were synthesized within AME (Adinolfi, et al., 1982). 
Following, a study found strong expression of HLA class I molecules in AME cells, 
including cells of the AM mesenchyme but no expression of HLA class II 
molecule (Kubo, Sonoda, Muramatsu, & Usui, 2001). HLA class Ib has been 
shown to be expressed on term AME cells with very little expression of HLA class 
Ia molecules (Dua, Gomes, King, & Maharajan, 2004). Also, it was shown that 
HLA class II molecules are expressed by amniotic mesenchymal macrophages 
with a large increase in expression with an increase in gestational age (Dua, 
Gomes, King, & Maharajan, 2004). More thorough investigations of HLA 
molecules expression or absence of such is suggested, which would increase 
and better our understanding of the low to no immunogenic properties of the AM. 
Also, AME cells have shown express the three complement factors: CD59, 
decay-accelerating factor (DAF), and membrane attack complex (MAC) inhibitory 
protein (MIP) (Kubo, Sonoda, Muramatsu, & Usui, 2001). CD59 and DAF are 
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known to protect cells against lysis by complement (Kubo, Sonoda, Muramatsu, 
& Usui, 2001). Expression of these factors on AME cells is suggestive that it is 
protective measures against maternal complement factors (Kubo, Sonoda, 
Muramatsu, & Usui, 2001).   
2.5.3 Promoter of Epithelialization 
The AM promotes epithelialization through two mechanisms, which are not 
mutually exclusive (Baradaran-Rafii, Aghayan, Arjmand, & Javadi, 2007). The 
first is the AM serving as a BM scaffold in which epithelial cells can migrate 
successfully (Dua, Gomes, King, & Maharajan, 2004). This AM scaffold 
reinforces adhesion of basal epithelial cells, promotes epithelial differentiation, 
and prevents epithelial apoptosis (Dua, Gomes, King, & Maharajan, 2004). The 
second means is by paracrine actions (Dua, Gomes, King, & Maharajan, 2004). 
In studies showing AM promotion of epithelialization, cytological and molecular 
assays show AME cells secreting EFG, TGF-, KGF, HGF, b-FGF, TGF-1, -2, -
3, and the expression of growth factor receptors including KGFR and HGFR by 
such cells (Dua, Gomes, King, & Maharajan, 2004). These factors and receptors 
play vital roles in epithelialization, and the expression of such suggest this very 
phenomenon (Dua, Gomes, King, & Maharajan, 2004). 
2.5.4 Inhibitor of Angiogenesis 
The AM has been shown to inhibit endothelial cell growth, inhibit 
neovascularization of the cornea, and decrease vascularization of the ocular 
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surface (Mamede, Carvalho, Abrantes, Laranjo, Maia, & Botelho, 2012). These 
studies suggest an overall anti-angiogenic property of the AM (Mamede, 
Carvalho, Abrantes, Laranjo, Maia, & Botelho, 2012). It is suggested that two 
factors are at work that promote such an anti-angiogenic effect of the AM 
(Mamede, Carvalho, Abrantes, Laranjo, Maia, & Botelho, 2012). The first is the 
physical barrier the AM provides, in which it acts by preventing diffusion of 
growth and migratory factors necessary for vascularization, specifically 
endothelial and vascular cell growth and migration (Mamede, Carvalho, Abrantes, 
Laranjo, Maia, & Botelho, 2012). Also, the AM has been shown to contain 
proteins involved in suppressing angiogenesis, and produce various anti-
angiogenic cytokines (Mamede, Carvalho, Abrantes, Laranjo, Maia, & Botelho, 
2012). Proteins believed to suppress angiogenesis that can be found in the AM 
include collage types IV and VII, laminin-1, and -5, and fibronectin; and anti-
angiogenic factors include endostatin, thrombospondin-1, which was shown to be 
expressed by AME cells but not found in the AM mesenchymal stroma 
(Fernandes, Mittanamalli, Sangwan, & Rao, 2005). The protein pigment 
epithelium-derived factor (PEDF) is expressed by the AM, and is known to 
suppress endothelial cell migration and proliferation, and retinal 
neovascularization (Dua, Gomes, King, & Maharajan, 2004).  
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2.5.5 Activator of Apoptosis 
The AM induces cell death or apoptosis in various cell types (Hori, Wang, 
Kamiya, Takahashi, & Sakuragawa, 2006; Li, He, Kawakita, Espana, & Tseng, 
2006). As discussed above, the AM suppresses the immune response through 
various cytokine factors, it is these factors that suppress and induce death in 
cells of the opposing, pro-inflammatory response (Hori, Wang, Kamiya, 
Takahashi, & Sakuragawa, 2006; Dua, Gomes, King, & Maharajan, 2004; John, 
2003). The AM has been shown to induce apoptosis in inflammatory 
macrophages through cell signaling effects including down-regulating NF-κB and 
Akt-FKHR signaling pathways (Li, He, Kawakita, Espana, & Tseng, 2006). AM 
transplants have also been shown to induce apoptosis in T lymphocytes, further 
down regulating the pro-inflammatory response, particularly T lymphocyte 
subsets responsible for macrophage type 1 cells (Hori, Wang, Kamiya, 
Takahashi, & Sakuragawa, 2006; Li, He, Kawakita, Espana, & Tseng, 2006). 
2.5.6 Anti-Fibrotic/Inhibitor of Scarring 
AME has been shown to inhibit scar formation and fibrosis by suppressing 
the activity of TGF-β, and TGF-β receptors found on AM stromal fibroblasts, 
inhibit fibroblast differentiation, which is induced by TGF-β (Hori, Wang, Kamiya, 
Takahashi, & Sakuragawa, 2006). Also, AM inhibits keratocyte to myofibroblast 
differentiation (Hori, Wang, Kamiya, Takahashi, & Sakuragawa, 2006). The 
myofibroblast cell is important in the latter stages of fibrosis and scarring 
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necessary for wound contraction (Baradaran-Rafii, Aghayan, Arjmand, & Javadi, 
2007).  
2.5.7. Anti-Carcinogenic 
AM-MSC have been shown to significantly reduce the proliferation of 
cancer cells of hematopoietic and non-hematopoietic cell lines (Magatti, De 
Munari, Vertua, & Parolini, 2012). Proliferation reduction via cell-cell contact and 
through unknown soluble factors arrests the cell cycle of these cancer cells in the 
G0/G1 phase (Magatti, De Munari, Vertua, & Parolini, 2012).  
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CHAPTER 3 
AMNIOTIC FLUID 
3.1 Historical Perspectives 
Scientific knowledge on AF was merely non-existent before the 1900s 
(Longo & Reynolds, 2010). Much knowledge on AF before the 20th century is 
immersed in mysticism, folklore, and superstitions, as was knowledge on the AM, 
which was discussed above in chapter 2 (Longo & Reynolds, 2010; Trelford & 
Trelford-Sauder, 1979). For millennia it had been known that the AF bathes the 
developing embryo and fetus (Longo & Reynolds, 2010). This knowledge, 
supplemented with the many mystical and religious beliefs associated with life 
and creation, established the many beliefs associated with the AF during this 
period (Longo & Reynolds, 2010). Referencing the amniotic fluid are the ancient 
Hindu scriptures the Upanishads, ancient Buddhist scriptures and scared texts, 
including the Christian Bible, and the holy Qu’ran of the Islamic faith (Carr, 2004; 
Elsaie, 2004; Olivelle, 1998; Shakya, 1998). These beliefs, although scientifically 
inaccurate, however, were nonetheless important in defining the vital and 
necessary roles of the AF in the creation and development of a new life (Longo & 
Reynolds, 2010). Below is a description of these many beliefs of the amniotic 
fluid prior to the 20th century. Following is a description of the scientific 
knowledge accrued on the AF at the turn of the 20th century.  
 
50 
 
3.1.1 Pre-20th Century 
3.1.1.1 Vedic Period (1700BCE–500BCE) 
Of all religious texts that make such references to the AF it is the 
Upanishads that are of the oldest (Olivelle, 1998). As mentioned above in 
Chapter 2, the Upanishads are philosophical texts considered to be the core of 
the Hindu religion (Olivelle, 1998). Referencing the AF is one of the thirteen 
principle Upanishads, Chāndoya Upanishad (Olivelle, 1998). The Chāndoya 
Upanishad, “you are that”, seeks to explain the origin of the universe (Olivelle, 
1998). Interestingly, in the Chāndoya Upanishad we are told that the universe 
developed from an egg that split in two upon hatching (Olivelle, 1998). Even 
more interesting, was the reference of two membranes of the egg, which have 
figurative representation, the outer membrane being the mountains, and the inner 
membrane, the AM, being the clouds and mist, mentioned above (Olivelle, 1998). 
Within the membranes is a fluid, AF, which represents the nourishing mother 
ocean (Olivelle, 1998). 
3.1.1.2 Ancient Greece (1200BCE–300BCE) 
Aristotle was the first to describe AF stained with meconium, which was 
associated with fetal death at the time (Iliodromiti, Grigoriadis , Vrachnis, 
Siristatidis, Varras, & Creatsas, 2012). The term meconium meaning “opium-like” 
is believed to derive from the color and appearance of AF stained with 
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meconium84. Aristotle described such an appearance of being black with a thick 
consistency very similar to processed opium (Iliodromiti, Grigoriadis , Vrachnis, 
Siristatidis, Varras, & Creatsas, 2012). This is one of the only mentions of AF in 
existing ancient Greek scientific texts (Iliodromiti, Grigoriadis , Vrachnis, 
Siristatidis, Varras, & Creatsas, 2012; Longo & Reynolds, 2010).  
3.1.1.3 Africa (700BCE-present) 
The Yorùbá culture dates back to the 7th century BCE, and entails people 
sharing common and ethnicity originating from the Southwestern region of 
Nigeria (Zenon, 2011). The Yorùbá culture and religion encompasses a vast 
array of rituals, prayers, stories, and spiritual beliefs (Zenon, 2011). These 
religious practices have become part of the many Caribbean, Middle American, 
and South American cultures of the West Indies for a vast majority of Africans 
sold in the slave trade were of Yorùbá decent (Zenon, 2011). The African Yorùbá 
culture places heavy significance in the AF in fertility and growth of a fetus 
(Zenon, 2011). One particular belief of the Yoruba culture is the power harnessed 
by the goddess and divine force, Yemoja (Zenon, 2011). Yemoja is believed to 
be the mother of waters, giving rise to all natural water resources, including the 
ocean and AF (Zenon, 2011). It is her influence and forces through the AF that 
drive the creation and sustainability of the life’s new creation, and the protection 
from death and disease (Zenon, 2011).  
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3.1.1.4 South Asia (500BCE-present) 
In Buddhism, Guanyin, a Bodhisattva of compassion, is depicted to be 
holding a willow branch in one hand and a flask that contains and pours the “Dew 
of Immortality” (Shakya, 1998). This Dew or fluid within the flask of which 
Guanyin holds is a nutritive broth or milk of elixir properties often thought to be 
equivalent to AF (Shakya, 1998). In Buddhist beliefs, AF was considered to be 
the nutritious broth that fed the fetus, which today is scientifically accurate 
(Shakya, 1998).  
3.1.1.5 Ancient Rome (500BCE-400AD) 
The Christian belief that one must be born again in order to be saved is 
stated in the bible, “Truly, truly, I say to you, unless one is born again, he cannot 
see the kingdom of God” (John 3:3) (Carr, 2004). The various Christian 
denominations have different interpretations of this quote (Carr, 2004). Many 
denominations, including Catholicism, believe being born again is the simple act 
of baptism (Carr, 2004). Others, specifically those of the Evangelical and 
Calvinist denominations, believe that the water being referenced is not baptism 
water but AF, and thus one must be born within the fluid of the AM to be born 
again (Carr, 2004). Thus, the very act of being born indicates a rebirth of a soul 
that will ascend to the Gates of Heaven upon their calling (Carr, 2004). 
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3.1.1.6  Western Africa (1100AD-present) 
The Akan culture is a matrilineal culture that entails the current ethnic 
groups of Africa’s Ghana and Cote d’Ivoire (Akhan, 2010). The origin of this 
culture dates back many centuries; however, the first firm establishment of this 
culture dates back to the 12th century (Akhan, 2010). The beliefs of this culture 
center on the universal governing of spirit-forces, Abosom (Akhan, 2010). These 
forces control creation, and all celestial bodies and matter of the universe (Akhan, 
2010). According to Akan beliefs, energy of a nurturing mother was equivalent to 
energy of the moon or bosom (Akhan, 2010). It was believed that the AF within 
the womb of the mother was physically and spiritually equivalent to Earth’s 
oceans (Akhan, 2010). The salt of the ocean was that of God’s tears, a means of 
ablution created to cleanse and purify the souls of the people (Akhan, 2010). The 
fluid of the womb, AF, served to hold a new creation in a state of purity for it was 
believed that the salt within keeps the fetus in such a state (Akhan, 2010). Also, 
according to Akan beliefs, it was the mother that had true influence on the spirits 
and physiology of the embryo and fetus (Akhan, 2010). It was assumed that the 
mother’s influence over the fetus was equivalent to the moon’s influence on the 
oceans of earth; bosom’s huge effect and influence on the rising and falling of the 
ocean’s tide on earth, so does the mother on her fetus by effecting the tides of 
the AF (Akhan, 2010). Thus, it is believed by the Akan culture that the AF is a 
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conductor of moods and emotion, and thus has not only an impact or effect on 
physiology of the developing fetus but also an effect on the spirits of the child 
(Akhan, 2010). These beliefs regarding the AF are still held among existing Akan 
people throughout the world (Akhan, 2010). 
3.1.1.7 Early Modern Period (1450AD-1750AD) 
In the 16th century Realdo Columbus, an Italian anatomist and surgeon, 
refuted the Hippocratic idea of “uterine paps” as the source of fetal nourishment 
(Power & Schulkin, 2012). Realdo Columbus correctly concluded that the fetus 
was protected by AF, but incorrectly postulated that this AF was the product of 
fetal sweat (Power & Schulkin, 2012).  
Also, in the 17th century The English physician William Harvey believed 
that the developing fetus received its nourishment from the AF by swallowing it, 
and by diffusion through pores in the skin of the fetus (Longo & Reynolds, 2010). 
Nicolas van Hoboken a Dutch anatomist and physician, through the study of cow 
fetuses, believed nourishment of the fetus was also through the AF (Longo & 
Reynolds, 2010). However, he incorrectly postulated that small pores in the CM, 
which allowed passage of molecules from the uterus or maternal blood 
circulation, were the derivation of such nourishment of the AF (Longo & Reynolds, 
2010). He also believed the CM and AM were not vascularized, and thus no 
maternal vascularization of the CM, which has been shown to be incorrect 
(Longo & Reynolds, 2010).  
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3.1.2 Post-20th Century 
3.1.2.1 Advent of the Amniocentesis (1870s) 
 The scientific study of AF at the turn of the 20th century can be most 
attributed to the advent of the amniocentesis (Magana & Shah, 2013; Uyeno, 
1919). Amniocentesis is the withdrawal of AF from the amniotic sac using a long, 
fine needle (Magana & Shah, 2013). German physicians Prochownick, Von 
Schatz and Lambi performed the first documented amniocentesis in the 1877 to 
relieve pressure on a fetus suffering from hydramnios (Magana & Shah, 2013; 
Uyeno, 1919). Following, Dr. Prochownick analyzed AF obtained from 
amniocentesis for sodium chloride, solid substances, and urea content (Uyeno, 
1919). And in 1891, Dr. Schroeder studied the content of solid substances, ash, 
and albumin in AF samples obtained from amniocentesis (Uyeno, 1919). It is 
uncertain if these studies conducted by Drs. Prochownick and Schroeder were 
conducted on human AF samples (Magana & Shah, 2013; Uyeno, 1919).  
3.1.2.2 Indication of Amniotic Fluid Cells (1950s-1970s) 
The first documentation in which the cellular composition of AF was 
analyzed can be attributed to the obstetrician Dr. Fritz Friedrich Fuchs and 
gastroenterologist Polv Riis (Magana & Shah, 2013). In 1956 they showed that 
fetal sex could be determined from AF cells taken from an amniocentesis by 
identifying the presence or absence of Barr bodies within these fetal cells 
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(Magana & Shah, 2013). After, the further characterization of AF cellular and 
non-cellular contents would ensue (Magana & Shah, 2013).  
Widespread prenatal screening introduced itself in the late 1960s wishing 
to both increase research in reproductive health and detect pregnancy as early 
as possible (Nadler, 1969). Routine screening of the fetus and AF brought about 
a heightened investigation of the cells within the AF (Nadler, 1969). Research on 
AF cells at the time was extremely limited often only including the culturing of 
such cells for morphological identification and genetic karyotyping (Nelson & 
Emery, 1973). In 1966 the first documented, successful culture of fetal AF cells 
for genetic screening was done by Dr. Steele and Dr. Breg (Kelley, 2013). The 
culture of fetal AF by Steele and Breg revealed two distinct morphological 
classes of cells: epithelial-like and fibroblast-like cells (Kelley, 2013). It was in 
1969, in the lab of Dr. Nelson and Emery of Edinburgh, Scotland, in which 
research in to AF cell culture modification and optimum growth settings occurred 
(Nelson & Emery, 1973). Here, it was first shown that AF cells adhered to glass 
surfaces promoting cell growth in culture (Nelson & Emery, 1973). It was 
concluded that successful, viable amniotic fluid cell growth occurred most 
significantly in AF obtained less than 20 weeks of gestation (Nelson & Emery, 
1973). Over the course of the next two decades, culture techniques would 
drastically improve, increasing both the acceleration of growth and viability of AF 
cells (Chang, Jones, & Masui, 1982; Martin, 1980; Porreco, Bradshaw , Sarkar, & 
Jones, 1980; Rudiger, Wolff, Wendel, & Passarge, 1974). Together with 
57 
 
improved growth conditions and advancement in cytological and biochemical 
technologies, further identification and understanding of AF cells and non-cellular 
composition of such fluid would ensue (Kelley, 2013; Chang, Jones, & Masui, 
1982; Martin, 1980; Rudiger, Wolff, Wendel, & Passarge, 1974). 
In 1971, the two principle cell types of AF cell culture initially demonstrated 
by Steele and Breg (above) were shown to be not only morphologically distinct 
but also biochemically distinct by opposing histidase activity in both cell class 
types (Melancon, Lee, & Nadler, 1971). Epithelial-like cells were shown to have 
histidase activity but fibroblast-like cells lacked histidase activity (Melancon, Lee, 
& Nadler, 1971). Hoehn et al. conducted further investigation on principle 
amniotic fluid cell types in 1974 (Hoehn, Bryant, Karp, & Martin, 1975). A large 
sample size of second trimester amniotic fluid cell cultivation revealed three main 
classes of amniotic fluid cells with corresponding proportions: 5.5% fibroblast-like 
cells (F-type cells), 33.7% epitheloid (E cells), and 60.8% previously identified AF 
specific cells (Hoehn, Bryant, Karp, & Martin, 1975).  
Following, in 1974 Sutherland et al. cultured AF specimens of second 
trimester pregnancies (Sutherland, Bauld, & Bain, 1974). Throughout the course 
of cultured samples, an inverted microscope was used to characterize cells 
based on morphology (Sutherland, Bauld, & Bain, 1974). Five cell types were 
readily identifiable and characterized throughout the study: macrophage cells, 
three types of E cells, and a F-Type cell (Sutherland, Bauld, & Bain, 1974).  
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In 1982 a study revealed the presence of goblet cells, urotheial cells, 
histiocytes, macrophages, AME cells, and umbilical cord cells in natural AF 
(Schrage, Bogelspacher, & Wurster, 1982). Unfortunately, the vast majority of 
cells in natural AF are washed off during the culture process, and thus explains 
why information on all AF cells is lacking, even today (Prusa & Hengstschlager, 
Amniotic fluid cells and human stem cell research - a new connection., 2002). It 
is believed that a large part of the washed off, non-adhering cells in culture are 
exfoliated squamous cells, including identified goblet cells, histiocytes, and 
macrophages (Prusa & Hengstschlager, Amniotic fluid cells and human stem cell 
research - a new connection., 2002; Schrage, Bogelspacher, & Wurster, 1982). 
With the increasing use of AF cells for prenatal diagnosis, the urge to 
identify congenital pathologies unidentifiable through karyotyping and cellular 
morphology brought about the identification of properties of AF cells previously 
unknown (Pollack, Heagney, Braun Jr., & O'Neill, 1981; Rosenmann, Schumert, 
Theodor, Cohen, & Brautbar, 1980). In 1980 the use of AF cells to identify and 
diagnose in utero congenital adrenal hyperplasia due to 21-hydroxylase 
deficiency and complement C4 deficiency, pathologies both known to be heavily 
linked to HLA expression, showed the expression of HLA antigens on amniotic 
fluid cells, particularly HLA-B homozygosity (Pollack, Heagney, Braun Jr., & 
O'Neill, 1981; Rosenmann, Schumert, Theodor, Cohen, & Brautbar, 1980). 
Further testing revealed the strong presence of HLA-A,-B, and –C antigens in AF 
cells with the absence of HLA class II molecules, particularly HLA-D class II 
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molecules – as shown above, indirectly (Pollack, Heagney, Braun Jr., & O'Neill, 
1981; Rosenmann, Schumert, Theodor, Cohen, & Brautbar, 1980; Valentine-
Thon, Kreeb, Grosse-Wilde, & Passarge, 1983). However, in 1984 Kreeb et al. 
found that a small subpopulation of cultured AF cells expressed HLA-DR class II 
molecules using monoclonal cDR antibodies (Kreeb, Valentine-Thon, 
Krumbacher, Grosse-Wilde, & Passarge, 1984). Such a discrepancy can be 
possibly attributed to the arbitrary definition of what is considered positive and 
negative for HLA class I and II. HLA class I molecules deemed negative in AF 
cell cultures in the study conducted by Zhang et al. was less than 2% positive 
(Kreeb, Valentine-Thon, Krumbacher, Grosse-Wilde, & Passarge, 1984; 
Valentine-Thon, Kreeb, Grosse-Wilde, & Passarge, 1983). The small population 
positive for HLA class II molecules in Kreeb et al. could possibly represent the 
small 2% found in the previous study (Kreeb, Valentine-Thon, Krumbacher, 
Grosse-Wilde, & Passarge, 1984). Future aspects of HLA typing would be used 
in research investigation of AF cells and stem cells to confirm fetal origin of such 
cells, and later confirmed to be responsible for low-immunogenicity of AF-derived 
stem cells (Kreeb, Valentine-Thon, Krumbacher, Grosse-Wilde, & Passarge, 
1984). Following, future testing of AF to identify congenital pathologies would be 
evaluated for a myriad of disorders (Aula, et al., 1980; Gosden & Brock, 1978; 
Gosden & Brock, Morphology of rapidly adhering amniotic-fluid cells as an aid to 
the diagnosis of neural-tube defects., 1977; Sutherland, Bauld, & Bain, 1974).   
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3.1.2.3 Identification of Amniotic Fluid Stem Cells (1990s-present) 
 The presence of cells in first trimester AF remained a mystery until 1993 
(Fauza, 2004). In 1993 Torricelli et al. cultured AF samples from the 7th to 13th 
weeks of gestation obtained from voluntary abortions (Fauza, 2004). Cells were 
identified in culture of AF samples of gestational weeks equal to or greater than 
11 weeks (Fauza, 2004). The morphology of identified cells in the 11th week of 
gestation included small nucleated, round cells, most consistent with 
hematopoietic progenitor cells (Fauza, 2004). The identification of progenitor 
cells in AF by this study was the first ever to signify a possible presence of stem 
cells in AF (Fauza, 2004).  
In 2001, Kaviani et al. mechanically isolated a subpopulation of cells of 
second trimester AF samples positive for smooth muscle actin, vimentin, 
cytokeratin 18, and fibroblast surface protein most consistent with a 
mesenchymal, fibroblast-myofibroblast cell lineage (Kaviani, Perry, Dzakovic, 
Jennings, Ziegler, & Fauza, 2001). After isolation, these cells were rapidly 
expanded in culture, and seeded on to an aceullar human dermis scaffold 
(Kaviani, Perry, Dzakovic, Jennings, Ziegler, & Fauza, 2001). These cells firmly 
adhered to the decellularized scaffold with increased density and with no 
evidence of cell death (Kaviani, Perry, Dzakovic, Jennings, Ziegler, & Fauza, 
2001). This experiment simply showed therapeutic potentials of AF cells, 
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strengthening the possible presence of stem cells within AF (Kaviani, Perry, 
Dzakovic, Jennings, Ziegler, & Fauza, 2001). 
Following, in 2003 Prusa et al. characterized a subpopulation of AF cells 
that expressed the transcription factor Oct-4, a “stemness” factor found in 
embryonic stem cells (Prusa, Marton, Rosner, Bernaschek, & Hengstschlager, 
2003). And in 2004 AMSC were isolated, cultured, expanded, and confirmed of 
fetal origin using HLA typing (Tsai, Lee, Chang, & Hwang, 2004). These cells 
were isolated based on cell morphology consistent with AFMSC above (Tsai, Lee, 
Chang, & Hwang, 2004). They showed multilineage differentiated potentials into 
fibroblasts, adipocytes, and osteoblasts (Tsai, Lee, Chang, & Hwang, 2004). Also, 
these cells showed a small subpopulation of Oct-4 (Tsai, Lee, Chang, & Hwang, 
2004).   
 In 2007 De Coppi showed that about 1% of AF cells expressed the stem 
cell factor receptor CD-117, or c-kit (Cananzi & De Coppi, CD117+ amniotic fluid 
cells., 2012). These cells were shown to differentiate in to all three germ layers 
(Cananzi & De Coppi, CD117+ amniotic fluid cells., 2012). It was this study that 
highly emphasized a population of AFDSC distinct from the originally identified 
AMSC (Cananzi & De Coppi, CD117+ amniotic fluid cells., 2012; Tsai, Lee, 
Chang, & Hwang, 2004; Kaviani, Perry, Dzakovic, Jennings, Ziegler, & Fauza, 
2001). What is uncertain is if these cells are truly representing an absolute 
heterogeneous stem cell clonal population. It has also brought about a 
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convoluted nomenclature of stem cells in AF, supported by a lack of information 
regarding their origin, and a non-concomitant expression of stem cell cytological 
and biochemical markers (Fauza, 2004). To be clear, amniotic fluid-derived stem 
cells (AFDSC) represent all stem cells found in AF, and amniotic fluid 
mesenchymal stem cells (AMSC) represent stem cells isolated by Kaviani et al. 
in 2001 and Tsai et al. 2004 (Tsai, Lee, Chang, & Hwang, 2004; Kaviani, Perry, 
Dzakovic, Jennings, Ziegler, & Fauza, 2001). Stem cell subpopulations found in 
AF said be distinct from AMSC, including CD117+ stem cells fall under AFDSC 
(Cananzi & De Coppi, CD117+ amniotic fluid cells., 2012). 
  In 2013, Ryan et al. investigated the expression of Oct-4 in fetal and 
placental mesenchymal stem cells (Ryan, Pettit, Guillot, Chan, & Fisk, 2013).  
Familiar with the major role of Oct-4 in embryonic stem cell but equipped with the 
knowledge of Oct-4 gene variants, pseudogenes, and isoform complexities, Ryan 
et al. concluded that studies identifying Oct-4 positive cell populations as stem 
cells were falsely led; and thus ultimately questioning the “stem-ness” of Oct-4 
positive stem cells in AF (Ryan, Pettit, Guillot, Chan, & Fisk, 2013). It should be 
known that identification of isolated AMSC, initially and current, for “stem-ness” 
was and is done using various characteristics, including cell morphology and 
cytological markers (Tsai, Lee, Chang, & Hwang, 2004; Kaviani, Perry, Dzakovic, 
Jennings, Ziegler, & Fauza, 2001). Oct-4 identification in AMSC was used for 
additional identification but never primary verification of “stem-ness” as were 
CD117+ cells (Ryan, Pettit, Guillot, Chan, & Fisk, 2013; Cananzi & De Coppi, 
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CD117+ amniotic fluid cells., 2012; Kaviani, Perry, Dzakovic, Jennings, Ziegler, & 
Fauza, 2001; Tsai, Lee, Chang, & Hwang, 2004). 
3.2 Volume and Regulation 
The volume and regulation of AF throughout gestation are functions of 
embryonic and extraembryonic membranes (Underwood, Gilbert, & Sherman, 
Amniotic fluid: not just fetal urine anymore., 2005). AF volume is influenced and 
regulated by six water and solute pathways each having a certain level of 
influence during normal and pathological states (Underwood, Gilbert, & Sherman, 
Amniotic fluid: not just fetal urine anymore., 2005; Brace, Physiology of amniotic 
fluid and volume regulation., 1997). Derivation of the AF is highly dynamic and is 
more than simply the diffusion of maternal plasma in to the developing amniotic 
cavity (Underwood, Gilbert, & Sherman, Amniotic fluid: not just fetal urine 
anymore., 2005; Brace, Physiology of amniotic fluid and volume regulation., 
1997). The state of volume of AF regulation is highly complex for it consists of 
the simultaneous occurrence of water and solute exchange among six pathways 
(Brace, Physiology of amniotic fluid and volume regulation., 1997).  
Early in gestation newly established amnioblasts form the membrane of 
the newly forming amniotic cavity within the primary ectoderm on day 8 post-
fertilization (Larsen, 1997). Existing between these amnioblasts and throughout 
gestation are intercellular tight junctions with varying permeability (Larsen, 1997). 
At the very beginning of amniotic sac development water of the maternal plasma 
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circulating in the establishing trophoblast is able to diffuse into the primordial 
amnion and thus establish its existence (Larsen, 1997). Throughout gestation 
these cells will function in the transfer of amniotic fluid between maternal 
circulation and the amnion fluid (Larsen, 1997).  
3.2.1 Intramembranous Pathway 
The first pathway is the intramembranous pathway, which is the exchange 
of fluid and solutes between AF and fetal blood perfusing fetal surface of the 
placenta, fetal skin, and the umbilical cord (Brace, Progress toward 
understanding the regulation of amniotic fluid volume: water and solute fluxes in 
and through the fetal membranes., 1995). In humans, the primary 
intramembranous pathway exchange occurs across the fetal surface of the 
placenta and the fetal vessels of the chorionic plate (Brace, Progress toward 
understanding the regulation of amniotic fluid volume: water and solute fluxes in 
and through the fetal membranes., 1995). This pathway is believed to play a 
major role in fluid volume and composition regulation in early gestation until full-
keratinization of fetal skin 22 weeks gestation from then of which it is thought to 
play a small, insignificant role in contribution and regulation of AF volume and 
composition (Brace, Physiology of amniotic fluid and volume regulation., 1997; 
Brace, Progress toward understanding the regulation of amniotic fluid volume: 
water and solute fluxes in and through the fetal membranes., 1995). Although 
minor in its role in later stage gestation in AF volume and composition, the 
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intramembranous pathway nutrient absorption does occur and is a function of 
para-cellular pathways and fetal blood stream permeability, indicating an 
influence regulated by hormones and molecules (Brace, Progress toward 
understanding the regulation of amniotic fluid volume: water and solute fluxes in 
and through the fetal membranes., 1995). In a near term fetus 200-500 ml of fluid 
is absorbed by the intramembranous pathway (Brace, Progress toward 
understanding the regulation of amniotic fluid volume: water and solute fluxes in 
and through the fetal membranes., 1995). It is believed that AF volume and 
regulation is controlled by numerous factors including trans-cellular vesicular 
transport mechanisms and the possibility of aquaporin proteins in fetal 
membranes, and hormone regulation including decidual prolactin thought to 
increase fetal membrane permeability (Brace, Physiology of amniotic fluid and 
volume regulation., 1997; Brace, Progress toward understanding the regulation 
of amniotic fluid volume: water and solute fluxes in and through the fetal 
membranes., 1995). 
3.2.2 Transmembranous Pathway 
Exchange between maternal membrane of the CM and of the fetal AM is 
the transmembranous pathway (Brace, Progress toward understanding the 
regulation of amniotic fluid volume: water and solute fluxes in and through the 
fetal membranes., 1995). This pathway is believed to play only a small role in AF 
volume in normal states throughout gestation, being most significant during initial 
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development of the amniotic cavity mentioned above (Brace, Progress toward 
understanding the regulation of amniotic fluid volume: water and solute fluxes in 
and through the fetal membranes., 1995). However, it has been shown that this 
pathway plays a significant role in regulating AF volume during times of maternal 
dehydration as shown by the increase in AF volume through this pathway during 
extreme maternal dehydration and fetal oligohydramnios; however, insignificant 
during normal state perturbations (Brace, Progress toward understanding the 
regulation of amniotic fluid volume: water and solute fluxes in and through the 
fetal membranes., 1995). It is believed that this pathway is highly regulated by 
maternal aldosterone and ADH (Underwood, Gilbert, & Sherman, Amniotic fluid: 
not just fetal urine anymore., 2005). Also, prostaglandin excreted by the fetal 
kidney and fetal lungs and also released by the AM and CM is thought to heavily 
influence the transmembranous pathway, possibly explaining an increased role in 
such during certain pathologies in which this hormone is increased (Sherer, 
2002). During later stages of gestation the transmembranous pathway 
contributes 0.3% of volume of fetal body weight, with flow of water in latter stages 
to be outward to be about 10 ml of amniotic fluid (Brace, Progress toward 
understanding the regulation of amniotic fluid volume: water and solute fluxes in 
and through the fetal membranes., 1995).  
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3.2.3 Fetal Urine Pathway 
The third pathway is that of fetal urine excretion by the fetus (Brace, 
Progress toward understanding the regulation of amniotic fluid volume: water and 
solute fluxes in and through the fetal membranes., 1995). Amniotic fluid volume 
in the second half of gestation is in large part due to the fetal urine pathway 
(Brace, Progress toward understanding the regulation of amniotic fluid volume: 
water and solute fluxes in and through the fetal membranes., 1995). Fetal urine 
first enters the amniotic sac at 8-11 weeks of gestation (Modena & Fieni, 2004). 
At about 25 weeks of gestation urine excretion is about 110 ml/kg for every 24-
hour period; and at about 39 weeks of gestation urine excretion is about 190 
ml/kg for every 24-hour period (Brace, Progress toward understanding the 
regulation of amniotic fluid volume: water and solute fluxes in and through the 
fetal membranes., 1995). At term, urine excretion is about 800-1200 ml/day 
(Brace, Progress toward understanding the regulation of amniotic fluid volume: 
water and solute fluxes in and through the fetal membranes., 1995).  
 3.2.4 Fetal Respiratory Secretion Pathway 
The fourth through sixth pathways include respiratory and oral-nasal 
secretions, and fetal swallowing (Underwood, Gilbert, & Sherman, Amniotic fluid: 
not just fetal urine anymore., 2005; Brace, Physiology of amniotic fluid and 
volume regulation., 1997). These pathways play a small role in amniotic fluid 
volume and composition when compared to the first three pathways (Underwood, 
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Gilbert, & Sherman, Amniotic fluid: not just fetal urine anymore., 2005; Brace, 
Physiology of amniotic fluid and volume regulation., 1997).  Not until recently did 
the idea of fetal lung secreted fluid in to the amniotic fluid become accepted 
(Brace, Physiology of amniotic fluid and volume regulation., 1997). Prior, fetal 
lung absorption was believed to be the main courses of action of which the fetal 
lungs endured, however, it has been elucidated that only under fetal asphyxia or 
severe distress do fetal lungs absorb amniotic fluid (Brace, Physiology of 
amniotic fluid and volume regulation., 1997). Normal fetal lung secretion, out flow 
from the trachea occurs under normal fetal episodes of breathing, half entering 
the amniotic fluid and roughly half being swallowed (Brace, Progress toward 
understanding the regulation of amniotic fluid volume: water and solute fluxes in 
and through the fetal membranes., 1995). For a near term fetus 340 ml of fluid is 
secreted from the lungs, 170 ml in to the amniotic fluid and 170 ml is swallowed 
(Brace, Progress toward understanding the regulation of amniotic fluid volume: 
water and solute fluxes in and through the fetal membranes., 1995).  
3.2.5 Fetal Oral-Nasal Secretions Pathway 
Oral secretions contribute only about 25 ml in to the amniotic fluid (Brace, 
Progress toward understanding the regulation of amniotic fluid volume: water and 
solute fluxes in and through the fetal membranes., 1995). Fetal oral-nasal 
secretions make small contributions to amniotic fluid volume and only during the 
latter stages of gestation (Underwood, Gilbert, & Sherman, Amniotic fluid: not just 
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fetal urine anymore., 2005; Brace, Progress toward understanding the regulation 
of amniotic fluid volume: water and solute fluxes in and through the fetal 
membranes., 1995).  
3.2.6 Fetal Swallowing Pathway 
Fetal swallowing is believed to play a significant role in amniotic fluid 
volume in the second half of gestation (Modena & Fieni, 2004). The fetus begins 
to swallow amniotic fluid at about the same time fetal urine excretion occurs, at 
about 8-11 weeks of gestation; with about 17 ml of amniotic fluid being 
swallowed in early gestation (Modena & Fieni, 2004). This volume does not 
include respiratory secretions swallowed before excreted into the amniotic sac 
(Modena & Fieni, 2004).  Animal studies have shown that prevention of fetal 
swallowing, fetal urine output remained normal and amniotic fluid volume was no 
different than controls (Gilbert & Brace, 1993). In near term fetuses about 500-
1000 ml of amniotic fluid is swallowed (Brace, Physiology of amniotic fluid and 
volume regulation., 1997; Brace, Progress toward understanding the regulation 
of amniotic fluid volume: water and solute fluxes in and through the fetal 
membranes., 1995). 
Overall, there is about 30 ml of amniotic fluid in an amniotic sac of 10 
weeks gestation and 190 ml at 16 weeks of gestation (Modena & Fieni, 2004). At 
the beginning of gestation until about fetal keratinization occurs amniotic fluid 
volume is a multiple of fetal volume with both volumes becoming equal at about 
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the 21st to 22nd week of gestation (Modena & Fieni, 2004). It should be known 
that during the last trimester there is a net increase of 30 to 40 ml of amniotic 
fluid volume per day (Modena & Fieni, 2004). Around the 30th week of gestation 
amniotic fluid volume is about half the volume of the growing fetus (Modena & 
Fieni, 2004). Also, at this time amniotic fluid volume is around 780-800 ml 
(Underwood, Gilbert, & Sherman, Amniotic fluid: not just fetal urine anymore., 
2005; Modena & Fieni, 2004). After 32-35 weeks amniotic fluid volume beings to 
decrease and at term the amniotic fluid volume is about one-quarter that of fetal 
volume with about 500-600 ml of amniotic fluid can be found in the amniotic sac 
of a term fetus (Modena & Fieni, 2004).  
The roles of fetal and extraembryonic membranes in volume and 
regulation are still poorly understood (Modena & Fieni, 2004; Brace, Progress 
toward understanding the regulation of amniotic fluid volume: water and solute 
fluxes in and through the fetal membranes., 1995). What is most confusing is the 
discrepancy one finds when comparing net amniotic fluid volume movement 
when compared to diffusion water factors of the intramembranous and 
transmembranous pathways (Brace, Progress toward understanding the 
regulation of amniotic fluid volume: water and solute fluxes in and through the 
fetal membranes., 1995). It is for this reason that studies and information that 
provide insight into water movement among the aforementioned pathways 
provide only a small amount of information in the regulation of amniotic fluid 
when pathways are examined holistically (Brace, Progress toward understanding 
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the regulation of amniotic fluid volume: water and solute fluxes in and through the 
fetal membranes., 1995).  
3.3 Non-Cellular Composition 
 The non-cellular composition of amniotic fluid include inorganic 
electrolytes, amino acids, peptides, and proteins, lipids, carbohydrates, growth 
factors, urea, and cytokines118. The composition of these molecules is a function 
of the embryonic and extraembryonic membranes, and thus changes throughout 
pregnancy (Underwood, Gilbert, & Sherman, Amniotic fluid: not just fetal urine 
anymore., 2005). Unfortunately, discussion of these molecules below does not 
address how they change as a function of gestational time but only includes their 
absolute presence throughout gestation.   
3.3.1 Inorganic Molecules 
 Sodium (Na+) and Chloride (Cl-) are the major inorganic electrolytes found 
in amniotic fluid (Uyeno, 1919). Their concentration within the amniotic fluid 
ranges from about 0.444% to 0.58% of amniotic fluid non-cellular composition 
(Uyeno, 1919). Other inorganic molecules found in the amniotic fluid but in trace 
amounts include K+, Ca2+, Li+, Rb+, Mg2+,Sr2+, and Ba2+ (Palavinskas, Kriesten, 
& Schulten, 1983).  
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3.3.2 Amino Acids and Carbohydrates 
Prior to fetal skin keratinization, amino acids freely diffuse from the 
amniotic fluid from maternal absorption to fetal circulation (Underwood, Gilbert, & 
Sherman, Amniotic fluid: not just fetal urine anymore., 2005). However, after 
keratinization of the fetal epidermis, amino acids obtained from the amniotic 
membrane are unable to free cross into the fetus, and thus concentration is 
increased in amniotic fluid (Underwood, Gilbert, & Sherman, Amniotic fluid: not 
just fetal urine anymore., 2005). Also, amino acids are excreted into the amniotic 
fluid through the fetal urine pathway (Underwood, Gilbert, & Sherman, Amniotic 
fluid: not just fetal urine anymore., 2005). Amniotic fluid is rich in the amino acid 
taurine, which is higher in concentration relative to fetal and maternal serum, 
which is the opposite for other amino acids (Underwood, Gilbert, & Sherman, 
Amniotic fluid: not just fetal urine anymore., 2005). Other amino acids found in 
amniotic fluid include but are not limited to glutamine and arginine (Underwood, 
Gilbert, & Sherman, Amniotic fluid: not just fetal urine anymore., 2005).  
Carbohydrates and their derivatives found in the amniotic fluid include 
glucose, fructose, lactate, and pyruvate (Underwood, Gilbert, & Sherman, 
Amniotic fluid: not just fetal urine anymore., 2005).  
3.3.3 Proteins and Peptides 
 Proteins found in amniotic fluid include, fibronectin, creatinine, -defensins, 
lactoferrin, lysozyme, bactericidal/permeability-increasing protein, calprotectin, 
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secretoty leukocyte protease inhibitor, psoriasin, and cathelicidin, -fetal protein 
(Underwood, Gilbert, & Sherman, Amniotic fluid: not just fetal urine anymore., 
2005; Krusius , Fukuda, Deli, & Ruoslahti, 1985). 
3.3.4 Growth Factors 
 Growth factors found in amniotic fluid include epidermal growth factor 
(EGF), transforming growth factor alpha (TGF-), transforming growth factor 
beta-1 (TGF-1), insulin-like growth factor I (IGF-I), erythropoietin (EPO), 
granulocyte colony-stimulating factor (G-CSF), macrophage colony-stimulating 
factor (M-CSF) (Underwood, Gilbert, & Sherman, Amniotic fluid: not just fetal 
urine anymore., 2005).  
3.3.5 Steroids 
 Steroids found in amniotic fluid include testosterone, androstenedione, 
dehydroepiandrosterone (DHA), DHA sulfate (DHAS), progesterone, 17 -
hydroxyprogesterone (17-OHP), estradiol, and hydrocortisone (Carson, Okuno, 
Lee, Stetten, Didolkar, & Migeon, 1982).  
3.3.6 Cytokines 
 Cytokines are found in small concentrations in amniotic fluid. These 
cytokines include Il-6, IL-8, TGF-, TNF-, IL-11, and IL-15. Cytokines found in 
very small concentrations in the amniotic fluid include IL-10 and IL-12 (Heikkinen, 
Mottonen, Pulkki, Lassila, & Alanen, 2001). 
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3.4 Cellular Composition 
3.4.1 Non-Stem Cell 
3.4.1.1 Cells of Uncultured Amniotic Fluid 
Using EM two main groups of cells can be identified in uncultured, natural 
amniotic fluid based on ultrastructure: large cells with irregular borders and small 
nuclei, later defined as squamous cells; and small round macrophage-like cells 
(Gosden C. M., Amniotic fluid cell types and culture., 1983; Cutz & Conen, 1978). 
Another study confirmed the presence of large squamous cells with and without 
keratinization, and with regular microvilli borders (Cutz & Conen, 1978). The 
macrophage-like cells initially identified were confirmed in this study showing 
phagosomes in and phagocytosis in vitro abilities of the second, macrophage 
cells (Cutz & Conen, 1978). However, it has yet to be identified exactly what 
proportions of these two classes of cells account for the cells found in cultured 
amniotic fluid mentioned below (Gosden C. M., Amniotic fluid cell types and 
culture., 1983; Cutz & Conen, 1978).  
3.4.1.2 Cells of Cultured Amniotic Fluid 
Cells found in natural amniotic fluid can be classified into three broad 
groups based on cell culture characteristics: attaching, colony-forming amniotic 
fluid cells; attaching non-colony forming, non-proliferative amniotic fluid cells; and 
non-attaching amniotic fluid cells (Prusa & Hengstschlager, Amniotic fluid cells 
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and human stem cell research - a new connection., 2002). The former group, 
attaching, colony-forming cells, has been significantly studied because of ease of 
cell culture growth, and is discussed below (Prusa & Hengstschlager, Amniotic 
fluid cells and human stem cell research - a new connection., 2002). Information 
and knowledge on the latter two groups is extremely limited (Prusa & 
Hengstschlager, Amniotic fluid cells and human stem cell research - a new 
connection., 2002). Also, it should be known that amniotic fluid cells identified in 
culture do not represent all cell types found in natural amniotic fluid (Prusa & 
Hengstschlager, Amniotic fluid cells and human stem cell research - a new 
connection., 2002). 
3.4.1.3 Initial 3 Cell Classes of Cultured Amniotic Fluid 
Cultured cell identification relies on morphological and culture growth 
characteristics (Hoehn, Bryant, Karp, & Martin, 1975). F-Type cells are spindle-
shaped cells, grow in parallel arrays, and show high growth potentials (Hoehn, 
Bryant, Karp, & Martin, 1975). E cells show intimate cell-to cell contact, resistant 
to trypsin detachment, and showed poor growth potential (Hoehn, Bryant, Karp, 
& Martin, 1975). The third group of cells are AF specific cells, which are indicated 
to be pleomorphic, and show intermediate growth potentials to those of F-type 
cells and E cells (Hoehn, Bryant, Karp, & Martin, 1975). These cells were briefly 
discussed above in the post-20th century historical perspectives section. 
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3.4.1.4 Five Cell Classes of Cultured Amniotic Fluid 
Further investigation of epithelial-like cells in amniotic fluid including AF 
specific cells and E cells using intermediate filament antibodies, specifically 
keratin and vimentin antibodies, and the use of indirect immunofluorescence 
revealed the presence of five subtypes of E cells found in AF cell culture 
(Virtanen, von Koskull, Lehto, Vartio, & Aula, 1981). Differentiated by their 
morphology, growth, and size E1 is the most common cell type in all cell cultures, 
pleomorphic in shape and size, fibroblast-like in morphology with bright fibrillar 
keratin-positive cytoplasms, showed no cell-to-cell interaction, and is also 
vimentin positive (Virtanen, von Koskull, Lehto, Vartio, & Aula, 1981). E1 cell 
subtypes were previously classified as AF cells mentioned above (Virtanen, von 
Koskull, Lehto, Vartio, & Aula, 1981). E2 cells show fibrillar organization of 
keratin and vimentin but lacked cell-to-cell organization of interaction, are large 
and flat in morphology, exhibited low growth and proliferation, and are present in 
all cell cultures but low in number (Virtanen, von Koskull, Lehto, Vartio, & Aula, 
1981). E3 cells are indistinguishable from E1 cells in size and morphology, but 
show keratin organization and cell-to-cell interaction, and diffuse vimentin-
positive fibrils in the cytoplasm of the cells (Virtanen, von Koskull, Lehto, Vartio, 
& Aula, 1981). E4 cells are classified by their rapid growth in culture, and show 
keratin organization and cell-to-cell interaction, and are present in a very small 
amount in culture (Virtanen, von Koskull, Lehto, Vartio, & Aula, 1981). E5 cells 
are morphologically large, multinucleated cells dispersed among the other cell 
77 
 
types in the AF culture (Virtanen, von Koskull, Lehto, Vartio, & Aula, 1981). Also, 
E5 cells show bright locations of keratin fibers but also stain for vimentin 
antibodies (Virtanen, von Koskull, Lehto, Vartio, & Aula, 1981). F-type cells are 
identified as vimentin-positive, keratin-negative cells (Virtanen, von Koskull, 
Lehto, Vartio, & Aula, 1981). Cultures that show F-type cells as the dominant cell 
type in culture are very limited in number (Virtanen, von Koskull, Lehto, Vartio, & 
Aula, 1981). Morphologically, E1, E3, and F-type cells are indistinguishable in 
culture, but can be differentiated by keratin and vimentin expression and cell-to-
cell interaction (Virtanen, von Koskull, Lehto, Vartio, & Aula, 1981). A positive 
immunofluorescence of keratin filaments in all cells except F-type cells, which 
includes both E cells and AF-specific type cells, strongly supports an epithelial 
origin of E cells and AF-specific cells (Chen, 1982; Virtanen, von Koskull, Lehto, 
Vartio, & Aula, 1981).  
3.4.2 Stem Cells 
Stem cell hallmark characteristics, or “stem-ness”, include self-renewal, 
multilineage differentiation, or pluripoteny/multipotency; and maintain a state of 
dedifferentiation (Niwa, Miyazaki, & Smith, 2000). Identification of stem cells 
relies on the presence of transcription factors not expressed in differentiated cells, 
multilineage differentiation in culture in vitro, and telomerase activity (Niwa, 
Miyazaki, & Smith, 2000). A lack of one of the many properties does not exclude 
a cell from being that of a stem cell (Niwa, Miyazaki, & Smith, 2000). In fact, 
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currently, the debate of an absolute definition defining “stem-ness” is ongoing, 
and entails a grey area in stem cell research (Niwa, Miyazaki, & Smith, 2000).   
Principle transcription factors expressed in embryonic stem cells include 
Oct-4, NANOG, and Sox-2 all of which play a crucial role in embryonic stem cell 
self-renewal and pluripotency (Niwa, Miyazaki, & Smith, 2000). More specifically, 
Oct-4 is considered the master regulator of self-renewal and pluripotency in 
these cells (Pesce, Wang, Wolgemuth, & Scholer, 1998). During human 
embryonic development, Oct-4 is restricted to the inner cell mass of the 
blastocyst, and upon implantation and bilaminar disc formation it is restricted to 
the epiblast (Pesce, Wang, Wolgemuth, & Scholer, 1998). After gastrulation, Oct-
4 expression is down-regulated in an anterior to posterior manner with 
expression found in germ cells thereafter (Pesce, Wang, Wolgemuth, & Scholer, 
1998). In adult bone marrow mesenchymal stem cells not only express the 
transcription factors Oct-4, NANOG, and Sox-2 are expressed (Pesce, Wang, 
Wolgemuth, & Scholer, 1998). Also, transcription factors expressed in adult stem 
cells not expressed in embryonic stem cells believed to maintain their “stem-ness” 
include Rex-1, SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81 (Pesce, Wang, 
Wolgemuth, & Scholer, 1998). Much of the research and data obtained from 
AFDSC including characteristics, properties, and potentials are from that of 
second semester amniotic fluid (Cananzi & De Coppi, CD117+ amniotic fluid 
cells., 2012; Da Sacco, De Filippo, & Perin, 2011).  
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Fibroblast-like cells isolated by Kaviani et al. have been shown to co-
express CD44 and CD105 along with the expression of Oct-4 but negative for 
CD34 (Tsai, et al., 2007). Also, a more in-depth analysis of AMSC was 
conducted in conjunct with the analysis of bone marrow-derived stem cells (Nadri 
& Soleimani, 2007). AMSC were shown to be phenotypically similar to 
mesenchymal-derived stem cells from other tissues and progenitors, and 
differentiated cells of mesenchymal origin, further confirming their mesenchymal 
stem cell identity (Nadri & Soleimani, 2007; Tsai, Lee, Chang, & Hwang, 2004). 
Also, these cells not only express markers of mesodermal lineage but also 
express markers found on ectodermal and endodermal lineage cells, and given 
the appropriate differentiation media, are able to differentiate into all three germ 
layers, as discussed previously (Roubelakis, et al., 2007).  
What distinguishes AMSC from adult mesencymal stem cells, includes 
greater expansion potential, longer telomeres but no telomerase activity, and T-
cell proliferation thus emphasizing its low-immunogenicity (In 't Anker, et al., 
2003). When compared to induced pluripotent stem cells (iPS) and embryonic 
stem cells, AMSC have a stable karyotype; and do not display tumorogenic 
potentials when transplanted into immune-compromised mice, and bypass 
present ethical issues, respectively (Poloni, et al., 2011; Sessarego, et al., 2008). 
Another characteristic of AMSC that make them ideal stem cells for use in 
regenerative medicine and tissue engineering is their significant clonogenicity, or 
doubling in vitro (Poloni, et al., 2011; Sessarego, et al., 2008). Such a 
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characteristic highlights their remarkable ability of self-renewal over time with 
continued genetic stability not found in iPS or adult stem cells, and without tumor 
production, found in embryonic stem cell culturing (In 't Anker, et al., 2003).  
A subpopulation of AFDSC discussed previously is CD117+, c-kit+, AF 
stem cells first isolated (Cananzi & De Coppi, CD117+ amniotic fluid cells., 2012). 
Cytocellular analysis shows that these cells are heavily marked with 
mesenchymal markers, but can differentiate into cells of all three germ layers 
(Cananzi & De Coppi, CD117+ amniotic fluid cells., 2012). CD117+ expression 
appears early in AFDSC from around 7 weeks of gestation with a peak 
expression at around 20 weeks gestation (Cananzi & De Coppi, CD117+ 
amniotic fluid cells., 2012). AF-derived stem cells are discussed in the discussion 
section below.  
3.4.2.1 OCT-4 Pseudogene Expression In AFDSC 
A study conducted by Ryan et al., mentioned above in the post-20th 
century historical perspectives on AF section, investigated the OCT-4 gene and 
its expression (Ryan, Pettit, Guillot, Chan, & Fisk, 2013). The Oct-4 gene has 3 
variants: Oct-4A – variant 1; Oct-4 variants B and C, variants 2 and 3, 
respectively; are smaller variants found in cell cytoplasms with no known function 
(Ryan, Pettit, Guillot, Chan, & Fisk, 2013). Also, there are 6 pseudogenes with 
homology very close to Oct-4A, including the variants 2 and 3 above (Ryan, Pettit, 
Guillot, Chan, & Fisk, 2013). One of the pseudogenes transcriptionally active 
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within cells is Oct-4B (Ryan, Pettit, Guillot, Chan, & Fisk, 2013). OCT-4B’s 
expression has been confirmed in cancer cells and adult bone marrow 
mesenchymal stem cells and term umbilical vein stem cells (Ryan, Pettit, Guillot, 
Chan, & Fisk, 2013). It is Oct-4A that expressed in embryonic carcinoma cells 
and embryonic cell lines, and thus gives “stemness” to these cells (Ryan, Pettit, 
Guillot, Chan, & Fisk, 2013). Studies wishing to identify the expression of Oct-4 
use antibodies that do not discriminate between the Oct-4A gene and its 
pseudogene Oct-4B, which both show nuclear localization and have similar 
molecular weights (Ryan, Pettit, Guillot, Chan, & Fisk, 2013). Also, this study 
found conflicting reports in the literature on other stem cell markers similar to 
Oct-4 expression (Ryan, Pettit, Guillot, Chan, & Fisk, 2013). One of the biggest 
issues this study found was the lack of symmetry between mRNA expression and 
protein expression of stem cell markers including Sox-2, Rex-1, NANOG, SSEA-
3, SSEA-4, TRA-1-60, TRA-1-81 (Ryan, Pettit, Guillot, Chan, & Fisk, 2013).  
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CHAPTER 4 
DISCUSSION 
The AM and AF possess complex and unique biological properties. These 
properties allow for the development and sustainability of the embryo and fetus. 
Most importantly, the AM and AF possess stem cells that have been utilized for 
diverse applications with far-reaching abilities and future potentials (Cananzi, 
Atala, & de Coppi, Stem cells from amniotic fluid, 2011; Da Sacco, De Filippo, & 
Perin, 2011; Dobreva, Pereira, Deprest, & Zwijsen, 2010). The unique qualities of 
these stem cells have allowed them and currently allow them to be utilized in 
regenerative medicine, tissue engineering, and gene therapy (Cananzi, Atala, & 
de Coppi, Stem cells from amniotic fluid, 2011; Da Sacco, De Filippo, & Perin, 
2011; Dobreva, Pereira, Deprest, & Zwijsen, 2010). Research into AF-derived 
stem cells has been extensive, more so than that of amniotic AM stem cells. 
Although many properties of AF-derived stem cells are currently known their 
origin and reason for existence is not (Fauza, 2004). 
A heterogeneous population of stem cells in AF is a hotly discussed topic 
among scholars. Evidence supporting such a population occurred in 2007 when 
de Coppi isolated and characterized CD117+ cells expressing Oct-4 with 
pluripotent properties from AF samples (Cananzi & De Coppi, CD117+ amniotic 
fluid cells., 2012). De Coppi emphasized that such cells were different from 
previously AMSC, fibroblast-like cells that expressed CD34 and CD105, markers 
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that were negative on CD117+ cells but had pluripotent and clonogeneic in vitro 
similarities (Cananzi & De Coppi, CD117+ amniotic fluid cells., 2012; Tsai, Lee, 
Chang, & Hwang, 2004).. Such heterogeneity can be the result of stochastic 
phenotype switching in progeny of a clonal population, a phenomenon that is 
possibly occurring among AF stem cells (Salathe, Van Cleve, & Feldman, 2009).  
 Stochastic phenotype switching is a phenomenon responsible for 
phenotypic heterogeneity in a genetically uniform population of cells exposed to 
identical external environments (Salathe, Van Cleve, & Feldman, 2009; Raser & 
O'Shea, 2005). Such a phenomenon is believed to be an evolutionary adaptation 
that occurs independently of random mutations and recombination at the genetic 
level (Salathe, Van Cleve, & Feldman, 2009). This stochastic phenotype 
phenomenon has shown to play a very important and relevant role in drug 
tolerance phenotypes in bacterial populations, somatic evolution of cancer cells, 
and cell differentiation in embryonic stem cells (Rocco, Kierzek, & McFadden, 
2013). Stochastic variation of cell populations, also defined as intrinsic molecular 
noise, is thought to be the result of the inherent random nature of biochemical 
reactions, specifically, gene expression and gene regulatory processes (Rocco, 
Kierzek, & McFadden, 2013; Raser & O'Shea, 2005). Ultimately, such stochastic 
fluctuations in gene expression and regulation heavily influence and determine 
downstream protein abundance (Raser & O'Shea, 2005). This variation in protein 
abundance within genetically identical cells of a population is thus responsible for 
phenotypic heterogeneity (Raser & O'Shea, 2005).  
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 It is believed that stochastic phenotype switching is evolutionarily 
advantageous, thought to optimize the fitness of a genetically identical population 
in a constant fluctuating environment for which random mutation and other 
natural selection processes are unable to correctly prepare a population for 
unforeseen environmental changes (Acar, Mettetal, & van Oudenaarden, 2008). 
Mathematical technique and analyses have been used to make sense of 
stochastic phenotype switching (Rocco, Kierzek, & McFadden, 2013; Acar, 
Mettetal, & van Oudenaarden, 2008). Interestingly, cell populations with high 
stochastic phenotype switch rates outgrow cell populations with slow stochastic 
switch rates in highly fluctuating environments; however, cell populations with 
high stochastic phenotype switch rates are outgrown by cell populations with 
slow stochastic switch rates in low fluctuating or static environments (Acar, 
Mettetal, & van Oudenaarden, 2008). It is then assumed that stochastic 
phenotype switching within a specific identical cell population is heavily 
influenced by environmental change frequency (Acar, Mettetal, & van 
Oudenaarden, 2008). Also, original cell populations with slow transcriptional 
activity accounting for increased stochastic fluctuation but fast translational 
activity shows stable cell heterogeneity but cell populations with fast translational 
activity show a single phenotype distribution within the cell population (Rocco, 
Kierzek, & McFadden, 2013). Such a phenomenon can possibly explain the 
heterogeneity of stem cell phenotypes in amniotic fluid (Tsai, et al., 2007; 
Roubelakis, et al., 2007). The nature of amniotic fluid in the second semester, 
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which shows a wide variation in stem cell phenotype, is highly dynamic in fluid, 
molecule, and cell type, correlating such an event with the heterogeneous 
phenotype of stem cells in second trimester amniotic fluid (Roubelakis, et al., 
2007; Modena & Fieni, 2004). The possibility of stochastic phenotype switching 
being the reason for the heterogeneity in amniotic stem cells one can then 
assume the origin of such cells is that of a single origin, which is still unknown. 
However, although phenotypes are heterogeneous, the morphology of such cells 
is consistent with the fibro-blast morphology identified by Kaviani et al. in 2001 
(Cananzi & De Coppi, CD117+ amniotic fluid cells., 2012; Kaviani, Perry, 
Dzakovic, Jennings, Ziegler, & Fauza, 2001). It also assumes that heterogeneity 
phenotypes will differ with each normal AF sample, which is consistent with 
studies (Cananzi & De Coppi, CD117+ amniotic fluid cells., 2012; Roubelakis, et 
al., 2007). 
 It is also important to note that cells cultured previously in the 1970s and 
1980s include stem cells that were unknown at the time (Dobreva, Pereira, 
Deprest, & Zwijsen, 2010; Gosden C. M., Amniotic fluid cell types and culture., 
1983). A comparison of morphology and cytocellular phenotypes of the original 
classes of cells of AF cell culture to AFDSC could help elucidate the 
heterogeneity or homogeneity of AFDSC within AF (Dobreva, Pereira, Deprest, & 
Zwijsen, 2010; Gosden C. M., Amniotic fluid cell types and culture., 1983). 
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 Discovering the origin of AFDSC would potentially put to rest whether the 
phenotypic heterogeneity of stem cells in AF is truly of a heterogeneous or 
homogenous clonal population. Cell markers greatly differ among AME cells, AM-
ESC, and AFDSC (Tsai, et al., 2007). Although these cells are phenotypically 
different, it does not justify that such cells are not related nor are of the same 
origin. A more detailed analysis of the ontogeny of AF stem cells is required but 
should not rule out the AM as a possible source without sufficient evidence. 
 Stem cells most closely resembling AF stem cells, particularly AMSC, are 
of Wharton’s Jelly (WJ) of the umbilical cord (Jeschke, Gauglitz, Phan, Herndon, 
& Kita, 2011). WJ stem cells morphologically have a fibro-blast like appearance, 
similar to AMSC isolated by Kaviani in 2001 (Jeschke, Gauglitz, Phan, Herndon, 
& Kita, 2011; Kaviani, Perry, Dzakovic, Jennings, Ziegler, & Fauza, 2001). These 
cells also express cell surface markers including CD34 and CD105; and have 
pluripotent properties in which they are able to differentiate into all three germ 
layers (Jeschke, Gauglitz, Phan, Herndon, & Kita, 2011).  
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